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ABSTRACT
Background: Chronotype, social jetlag, poor sleep, proinflammatory diet, and low
physical activity have been associated with increased risk of chronic diseases: obesity,
diabetes, cardiovascular disease, depression and cancer. Yet the relationships between
these factors have not been extensively investigated in prospective studies.
Methods: Two studies were conducted. The first study followed 390 healthy men and
women ages 21-35 for two years. Social jetlag [SJL] and sleep measures (total sleep time
[TST], sleep onset latency [SOL], wake after sleep onset [WASO]), sleep efficiency
[SE]), were derived from physical activity personal (armband) monitoring. The
participants wore the armband for 4-10 days at 6-month intervals (1,431 observations).
Temporal consistency of repeated sleep measures was analyzed using generalized linear
mixed models (GLMM). Repeated measures latent class analyses (RMLCA) identified
subgroups among participants with adequate or inadequate sleep characteristics over
time. Relationships between chronotype, absolute SJL, sleep measures and
anthropometric measures (Body Mass Index [BMI], Percent Body Fat [%BF], Waist-toHip Ratio [WHR], Waist-to-Height Ratio [WHtR], Systolic Blood Pressure [SBP] and
Diastolic Blood Pressure [DBP], Total Mood Disturbance score [TMD], and Perceived
Stress Score [PSS]) were analyzed using GLMM for repeated measures. Stratification by
latent chronotype group was used to study effect modification.
The second study examined association between energy-density Dietary Inflammatory
Index (e-DII) and incident PrCA among 40,161 men ages 45-69 at recruitment
iv

(2002-2003) and followed for a mean of 9.7 years. The e-DII was calculated from a food
frequency questionnaire (FFQ) at baseline and categorized into quartiles. Incident PrCA
cases were ascertained via linkage with cancer registry and categorized into three groups:
high-risk, intermediate and low-risk. Accelerated failure time models were fit to model
time-to-development of incident PrCA. Cox proportional hazards models were used to
calculate hazard ratios (HR) and 95% confidence intervals (95% CI) of high- and
intermediate risk PrCA. In all analyses, the lowest quartile of e-DII representing a more
anti-inflammatory diet was used as the referent group.
Results: Minor temporary changes were observed only for SJL, chronotype and TST.
The RMLCA identified two groups of absolute SJL: low (mean±SE: 0.8±0.6 h, 58%) and
high (1.4±0.8, 42%); the latter were employed and had an evening chronotype.
Subgroups with disrupted sleep tended to be male, African American, have a lower
income, and an evening chronotype relative to those with normal sleep. Chronotype and
absolute SJL were not associated with anthropometric characteristics. TST <6 h, SE
<85% or WASO ≥60 min increased odds of high %BF, WHR or WHtR in participants
with early chronotypes. Those with early chronotypes and sleep latency ≥12 min had 1.9
times increased odds of high SBP (95%CI: 1.15-3.16, pinteraction=0.02). Among late
chronotypes, TST <6 hours was associated with 2.6 times increased odds of high SBP
(95%CI: 1.08-6.40, pinteraction=0.74).
Time-to-development of incident total PrCA did not differ by quartile of e-DII;
although, among Whites, it was shorter relative to other races (AFQ4 vs.Q1=1.16;
95%CI:1.01-1.34). The hazard Ratio (HR) for high-risk PrCA was increased by 36% in
the third quartile of the e-DII (95%CI:1.04-1.76); no increased risk was observed in the
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fourth quartile. The HR for high-risk PrCA was the highest among Blacks (HRQ3
vs.Q1=3.77;

95%CI:1.29-11.06). The e-DII was not associated with intermediate- or low-

risk PrCA incidence.
Conclusions: Sleep disruption among young adults remained persistent during two years.
Chronotype modified the association between disrupted sleep, obesity and elevated blood
pressure. Pro-inflammatory diet increased risk of high-risk PrCA especially among
Blacks.
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CHAPTER 1
Introduction
Background & Significance
Most physiological and behavioral processes in humans follow approximately 24hour cycles generated by self-sustaining internal circadian clocks (1). These free-running
cycles are synchronized by environmental stimuli called zeitgebers, and the most
important zeitgeber is light (2). Due to the difference in circadian entrainment
characteristics, differing in their preferences for timing of daily activities people may be
categorized into morning, neutral and evening chronotypes (3, 4). People with early
chronotypes, the so-called "larks", wake up and go to bed at night early while those with
late chronotypes ("owls"), prefer to wake up and go to bed late (3). For instance, on free
days, people with morning chronotypes go to bed on average between 10 p.m. and
midnight while those with evening chronotypes retire between 1 and 3 a.m. (3). Morning
and evening chronotypes differ in daily rhythms of many physiological processes such as
body temperature, melatonin and cortisol secretion, behavioral patterns and mood (5-7).
Due to variation in circadian clock genes and environmental factors, chronotypes in
populations are characterized by an approximately normal distribution from extremely
early to extremely late with the majority in the middle (3, 6). In addition, chronotypes are
influenced by age, sex, photoperiod of birth, genetic factors, employment status and work
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schedule, race, altitude and latitude of residence, exposure to light, season, and social
factors (7-11).
Hectic modern life in industrialized countries imposes on individuals multiple
work and social life related demands, and, through which, a schedule that often comes
into conflict with the individual's chronotype. This discrepancy (misalignment) between
biological preference and social clock is called "social jetlag" (SJL) (6). Individuals with
evening chronotypes tend to accumulate sleep debt during the week for which they try to
compensate during the weekend. Morning chronotypes, on the contrary, tend to develop
sleep debt during the weekend (6). Social jetlag can start in teenage years and continue
throughout working years until retirement and, thus, may affect millions of people in
industrialized countries (12).
The extreme form of circadian misalignment is caused by shift work when an
individual has to work at night and sleep during the day. People with different
chronotypes have different abilities to adjust to shift work (13, 14). For instance, people
with morning chronotypes have decreased tolerance to shift work, particularly to night
shifts (13, 14). They accumulate larger sleep debt, have poorer quality of daytime sleep
and are more likely to withdraw from shift work as compared to people with evening
chronotypes (13, 14). Chronic jetlag in humans, for instance, in flight attendants working
in long-distance transmeridian flights, is associated with impaired cognitive function
(15), menstrual disturbances (16, 17), mood disorders (18) and cancer (19). Chronic
jetlag was associated with increased mortality in aged mice (20). Since the circadian
clock regulates metabolism and homeostasis in many tissues, circadian disruption may
predispose millions of people to chronic diseases such as obesity, metabolic syndrome,
2

type 2 diabetes, depression, mood disorders, cardiovascular disease and cancer, similar to
what has been described among shift workers (21-29). Thus, it is important to investigate
complex relationships between individual circadian preference, circadian misalignment
and disease risk taking into consideration various other factors that may be involved
(genetic, demographic, behavioral, environmental).
The relationships between chronotype, mood and stress have recently received a
lot of attention although the underlying mechanisms are not clear (7). There is evidence
of higher incidence of evening chronotype (“eveningness”) among patients with
psychiatric conditions such as major depression and bipolar disorder (30-33), and that
eveningness is associated with depressive symptoms and elevated stress in healthy
individuals (34-44). Some studies, however, argue that morning chronotype
(“morningness”) also may be associated with altered health (22, 45-47). In some studies,
people with morning chronotypes reported difficulties staying asleep in early morning
hours and had elevated morbidity assessed with Nottingham Health Profile (45).
Morningness has been associated with elevated blood pressure, altered metabolic
parameters (46, 48) and decreased adaptability to shift work (13, 14). It is plausible that
both morningness and eveningness can be associated with mood changes; these
relationships are complex and the role of other influential factors needs to be explored.
Although chronotype is strongly correlated with SJL (6, 12, 37, 49), only a few studies
explored the relationships between SJL, alterations in mood, and depression (6, 36, 37).
Results of two studies suggested that the relationships between SJL and depression may
be modified by chronotype (37, 50); however, these studies disagreed with regard to
whether it is a morning or evening chronotype that predispose to depression. Thus,
3

studies are needed to explore the relationships between chronotype, SJL and mood or
stress using a longitudinal study design (to explore the temporality) that includes
mediation analysis.
There is evidence that chronotype is associated with obesity (12, 33, 51-55), and
in most studies those with an evening chronotype had a higher risk (12, 33, 51, 53-56).
However, some other studies either refute any association between chronotype and
obesity (57) or show that morning chronotypes also have an elevated risk of obesity and
even cancer (12, 22, 47). Social jetlag has been associated with increased body mass
index (BMI), body fat, waist circumference, metabolic syndrome, and markers of
systemic inflammation independently from sleep duration (12, 49, 58). Chronotype in
combination with inappropriate social schedule causes social jetlag (6, 12); thus, it is
reasonable to hypothesize that social jetlag may mediate the relationship between
chronotype and obesity. The only study that explored this potential mediating role of
social jetlag using mediation analysis produced conflicting results (56). Thus,
interrelationship between chronotype, SJL, BMI and other adverse metabolic or
psychological outcomes remains unresolved.
Recently, relationships between sleep characteristics and various health outcomes
such as obesity, type 2 diabetes, hypertension, cardiovascular disease and cancer have
been examined in prospective studies (59-65). Yet, in most of these studies chronotype
and other sleep measures were defined based only on self-report at baseline under the
assumption that they were accurately reported and did not change during the study
period. To date, only a few studies have investigated the variability of sleep
characteristics over prolong periods of time using objective measures such as
4

polysomnography or actigraphy (66-68). Thus, longitudinal studies of sleep
characteristics utilizing objective measurements are needed to investigate sleep
variability, especially in young adults.
Recent research suggests that if insufficient or disrupted sleep along with
proinflammatory diet and low physical activity persist for many years they may be
associated with increased risk of cancer, possibly via oxidative stress, inflammation, and
altered immune response (28, 69, 70). The complex relationships of previously
mentioned life style factors in pathogenesis of prostate cancer, especially in longitudinal
studies, have not yet been studied and, thus, require further investigation. According to
Global Burden of Cancer Study (GLOBOCAN) data, prostate cancer is the second most
frequently diagnosed cancer in men worldwide, and its incidence rates are the highest in
Australia/New Zealand, Eastern and Western Europe, and North America (71). In the
United States, incidence and mortality from prostate cancer differs by race/ethnicity and
socioeconomic status (72, 73). In addition, in immigrants, prostate cancer incidence
increases to the levels characteristic of the destination population (74, 75). This suggests
that in addition to differences in screening practices, differences in lifestyle factors may
play a role.
Diet is an important lifestyle risk factor for prostate cancer and yet summary
measures of the diet used in previous investigations of these relationships had some
limitations. For instance, an estimation of single nutrient intakes did not account for the
complex relationships between multiple nutrients in the individual's complete diet (76).
Dietary patterns are difficult to standardize, and some dietary indices only assessed
adherence to dietary recommendations that changed over time (77-79). Developed by the
5

researchers at the University of South Carolina, the Dietary Inflammatory Index (DII)
allows calculations of an inflammatory potential of the individual's diet and, thus, is a
biologically-based summary measure for studies of the relationships between diet and
health outcomes that are strongly based on inflammatory mechanisms (80, 81). The DII
was based on an extensive published literature, standardized against actual food intakes
in 11 populations around the world (USA, Mexico, England, Denmark, India, Australia,
New Zealand, Bahrain, Scotland, South Korea and Japan) (82), and validated in
epidemiological studies against inflammation biomarkers (83). Due to its unique ability
to assess the inflammatory potential of the diet, the DII would be a useful measure to
investigate the pathogenesis of prostate cancer, both alone and in combination with other
key lifestyle factors, namely sleep and physical activity. The latter two factors also may
increase predisposition to prostate cancer via oxidative stress and inflammation (28, 84,
85).

Objectives & Specific Aims
The proposed study has the following objectives: 1) evaluate the stability of
chronotype, SJL, and sleep disruption during two years; 2) examine the relationships
between chronotype, SJL or disrupted sleep and obesity, blood pressure, mood states,
stress and poor sleep; and 3) explore the role of inflammatory potential of diet and
lifestyle factors, such as sleep and physical activity in pathogenesis of prostate cancer.
The project has the following specific aims:
Specific Aim 1: Determine whether chronotype, social jetlag and disrupted sleep change
within two years. Disrupted sleep is defined by the following measures: total sleep time
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(TST), sleep onset latency (SOL), wake after sleep onset (WASO), and sleep efficiency
(SE).
Hypothesis: Chronotype, social jetlag and disrupted sleep remain stable within two years.
Specific Aim 2: Examine relationships between chronotype, SJL, objective sleep
characteristics (TST, SOL, WASO, SE) and various health indicators including: BMI,
percent body fat (%BF), waist-to-hip ratio (WHR), waist-to-height ratio (WHtR), systolic
blood pressure (SBP), diastolic blood pressure (DBP), mood, stress, and poor sleep.
Hypothesis 1: People with extreme chronotype (morning or evening) are more likely to
have: elevated BMI, %BF, WHR, WHtR, SBP, DBP, altered mood states (depressive
symptoms), stress or disrupted sleep than those with intermediate chronotype.
Hypothesis 2: People with higher SJL are more likely to have: elevated BMI, %BF,
WHR, WHtR, SBP, DBP or altered mood states (depressive symptoms), stress, disrupted
sleep than those with lower SJL.
Hypothesis 3:People with disrupted sleep are more likely to have elevated BMI, %BF,
WHR, WHtR, SBP, DBP, altered mood states (depressive symptoms) or stress than those
whose sleep is not disrupted.
Specific Aim 3
Specific Aim 3, sub-aim 1: Determine whether the e-DII is associated with prostate
cancer incidence and investigate potential effect modification by race.
Hypothesis 1: Men with higher (pro-inflammatory) e-DII scores will have an elevated
risk of prostate cancer.
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Hypothesis 2: Prostate cancer incidence among men with higher e-DII is further elevated
among African-Americans as compared to other races.
Specific Aim 3, sub-aim 2: Study relationships between the e-DII and high-risk prostate
cancer and the role of effect modification by race.
Hypothesis 1: A pro-inflammatory diet (as measured by the DII) predisposes individuals
to an elevated risk of advanced or aggressive prostate cancer.
Hypothesis 2: The incidence of advanced or high-aggressive prostate cancer in men with
higher DII is further elevated in African-Americans, with low total physical activity,
short sleep duration, elevated BMI or decreased in those who use NSAID.

Study outline
Chapter 2 first introduces concepts of individual circadian preference
(chronotype) and SJL followed by a review of studies of the relationships between
chronotype or SJL and disrupted sleep, mood disorders, stress, obesity and basic vital
signs (blood pressure, heart rate). Further, a summary of current literature on temporal
patterns of sleep characteristics and insomnia is presented. Chapter 2 concludes with the
review of the current knowledge about the relationships between individual's diet,
physical activity and sleep and prostate cancer risk. Chapter 3 describes research methods
used for each specific aim, including description of data sources and analytical methods.
Chapter 4 is a manuscript for Specific Aim 1: Temporal pattern of chronotype, social
jetlag and disrupted sleep within two-year time frame. Chapter 5 is a manuscript
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addressing Specific Aim 2: Relationships between chronotype, SJL or sleep
characteristics and anthropometric indices of obesity, blood pressure, mood and stress.
Chapter 6 is a manuscript on Specific Aim 3: Relationships between diet, physical
activity and sleep and prostate cancer risk. Chapter 7 includes overall summary and
suggestions for the future research.
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CHAPTER 2
Literature review
Introduction to chronotypes
Most physiological and behavioral processes in humans have a diurnal rhythm
(1). This daily rhythm is generated by a self-sustaining internal circadian clock located in
the suprachiasmatic nuclei of the brain (2). The central circadian clock generates rhythms
that are slightly longer than 24 hours; thus they have to be synchronized (or entrained) by
environmental stimuli to be more closely aligned with the 24-hour light dark cycle (2).
The most important synchronization stimulus (zeitgeber) is light (2, 86). Due to
differences in genetic predisposition and circadian entrainment stimuli, individuals differ
in their preferences for timing of daily activities and are typically categorized into
morning, neutral and evening chronotypes (3, 4). People with early chronotypes, the socalled "larks", wake up early and go to bed early, between 10 and 11 p.m., while those
with late chronotypes ("owls"), prefer to wake up later and go to bed later, between 11
p.m. and 1 a.m. (3). Chronotype is an individual trait influenced by genetic predisposition
(9, 87), possibly photoperiod of birth (7), and modulated by environmental (geographic
location of residence and light exposure) (7), and social factors (36). Due to variation in
circadian clock genes and environmental factors, chronotypes in populations have an
approximately normal distribution from extremely early to extremely late with the
majority in the middle (3, 6). Chronotype may vary by age and sex. For instance, children
10

tend to have early chronotypes that gradually progress to late chronotypes reaching the
peak of "lateness" in early adulthood (20 years) and then gradually become earlier and
earlier for the rest of their life (88). Women reach the peak of their chronotype
eveningness slightly earlier than men, and then, on average, have earlier chronotypes than
men until the age of 60 years when chronotypes become very similar for both sexes and
earlier than they were in childhood (88).
Social jetlag
Due to the differences between biologically preferred and social schedules (e.g.
school, work), individuals with evening chronotypes accumulate sleep debt during the
week for which they compensate during the weekend. Morning chronotypes, on the
contrary, develop sleep debt during the weekend (6). They delay their bed time due to
social interactions with later chronotypes but cannot sleep longer the next morning
because of their circadian rhythm determined earlier wake-up time. This discrepancy
between biological preference and social clock is called "social jetlag" (6). Originally, the
term "jetlag" was described in relation to transmeridian travel as a complex of
characteristic symptoms: difficulties falling asleep or staying asleep at night followed by
daytime fatigue, loss of concentration, irritability, altered appetite and bowel irregularity
due to the phase shift that occurs between the body’s internal clock and the ambient lightdark cycle in the new location (89, 90). The major difference between aforementioned
two types of jetlag is that while travel-associated jetlag is transient, social jetlag is
chronic and may adversely affect mood and behavior, and contribute to development of
chronic health conditions such as obesity (6, 12, 49). Some suggest that in industrialized
countries, over two-thirds of healthy adults are at risk of chronic social jetlag, although
11

few studies have addressed its potential health impacts (12, 49). An evening chronotype
positively correlates with amount of sleep debt accumulated during the week (6) and thus
with social jetlag (37).
Chronotype, social jetlag, and obesity
Circadian clock regulates metabolism and obesity; thus, circadian misalignment
may lead to obesity and metabolic syndrome via altered metabolic processes, lack of
physical activity and poor eating habits (49, 52, 91-94). Circadian misalignment may lead
to lipid disregulation, decreased insulin sensitivity, impaired glucose tolerance and
altered cortisol secretion (49, 52, 91). Short sleep duration has been associated with
disregulation of metabolic hormones leptin and ghrelin, which increase appetite and
cravings for energy dense foods (95).
In a cross-sectional study among patients with bipolar disorder, chronotype
explained 19% of the variation in total body fat (after adjustment for age, sex, mood and
sleep disruption), and “eveningness” was associated with increased total body fat (51). In
another study, chronotype was a significant predictor of BMI in people with normal
weight (BMI 18.5-<25 kg/m2), and morningness was associated with increases in BMI
(12). Social jetlag did not predict BMI in people with normal weight; however, in
overweight and obese, SJL rather than chronotype was positively associated with BMI
(12). Recent experimental studies show that chronotype and circadian misalignment
affect glucose tolerance via different mechanisms and independently from behavior (52).
Several studies found that evening circadian preference is associated with
increased body weight in different age groups (33, 53-55). Depressed peri- and post-
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menopausal women with evening chronotype and delayed mid-sleep time had higher
BMI and were prone to weight gain compared to those with morning chronotypes and
less delayed mid-sleep phase (33). Delayed mid-sleep time was associated with increased
risk of obesity in elderly men and women in two cohort studies of Osteoporotic Fractures
(96). In a follow-up study of healthy college freshmen, evening chronotype was
associated with increase of BMI while there was no change among morning and neutral
chronotypes combined in one group (53). A recent cross-sectional study supports this
observation that evening chronotypes are more likely to have higher BMI than
intermediate and morning chronotypes combined in a representative sample of US adults
18-71 years old (55). In another cross-sectional study in adolescent girls, however,
evening chronotype was not associated with increased BMI (57). The mechanism
underlying the relationship between chronotype and obesity has not yet been established.
It is possible that some other factors such as short sleep duration, sleep/wake
disturbances, stress-behavioral patterns (changes in diet or physical activity), or mood
may play a mediating role. Some studies suggest that persons with late chronotype,
especially those who are depressed, have increased appetite and carbohydrate cravings
(33) and consume unhealthy foods (93, 94) that predispose them to obesity. In a crosssectional study of US adults aged 18-71 years, relationships between chronotype and
BMI were mediated by self-control (55). Chronotype and social jetlag are moderately
correlated, especially on work days, and people with evening chronotypes tend to have
more social jetlag (6, 12, 37, 49, 58). Social jetlag has been associated with increased
BMI, body fat, waist circumference, metabolic syndrome, and markers of systemic
inflammation (12, 49, 58). Chronotype in combination with social schedule can elicit
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increase in social jetlag (6, 12); thus, it is reasonable to hypothesize that social jetlag may
mediate the relationships between chronotype and obesity. The only study that explored
this potential mediating role of social jetlag using mediation analysis produced
conflicting results (56). One hundred thirty seven college freshmen attending an urban
US university were enrolled in the study during the second week of the fall semester, and
fifty-four of them were followed up eight weeks later (53, 56). Upon enrollment and at
the follow-up, the students completed several self-administered questionnaires including
the 5-item reduced version of Morningness-Eveningness Questionnaire used to define
chronotype (97). Their chronotype did not change significantly during the study period,
and a sensitivity analysis showed that completion status and chronotypes were not related
(53). Those who completed the study did not differ from noncompleters by weight, BMI,
sleep quality and physical activity at the baseline. The authors used linear regressions to
model changes of BMI and mood during the study period based on chronotype (53). In
the mediation analyses, the direct effect of chronotype on BMI could not be evaluated
because of the violation of the two key assumptions, normality (for BMI) and statistical
significance of the association between exposure (chronotype) and outcome (BMI);
therefore, only the indirect effect was studied using a nonparametric bootstrap approach
(56). Chronotype was modeled as a dichotomous variable; evening chronotypes were
compared to morning and neutral chronotypes combined in one group due to the very
small number of participants with morning chronotypes (56). The bootstrap analysis
showed that evening chronotypes had higher SJL and the latter was associated with
increase in BMI. This suggests that chronotype has indirect effect on BMI through the
SJL; however, the final test for mediation (Sobel test) was not statistically significant
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(56). Post hoc analyses showed that when chronotype was modeled as a continuous
variable, later chronotype increased BMI via increase in SJL, and this conclusion was
supported by a statistically significant Sobel test (56).
Some researchers evaluated relationships between chronotype, social jetlag and
measures of obesity by incorporating both chronotype and social jetlag into their
statistical models at the same time (12, 58). This approach may introduce
multicollinearity which can increase the potential for Type 2 error (false negative). We
propose to start with an evaluation of the correlation between chronotype and social
jetlag and then conduct mediation analyses between chronotype and SJL as they relate to
the metabolic and psychometric outcomes included in this study. The results of the
mediation analysis will help develop an unbiased understanding of the roles of these
factors in physical and psychological health.
Few studies have investigated relationships between chronotype/social jetlag and
overweight/obesity. Circadian disruption is highly prevalent in industrialized countries
and may contribute to obesity or other adverse metabolic outcomes. The Energy Balance
data will allow for an examination of these questions in a longitudinal study with 2-years
of follow-up; the planned analyses will use BMI, BF%, WHR, and WHtR. While BMI is
more convenient and widely used, it is only a surrogate measure and has been shown to
underestimate obesity (98-100) since it doesn't distinguish between fat and muscle tissue
(101). BF% measured by dual X-ray absorptiometry is considerably more precise than
BMI; it measures bone, muscle and fat tissues simultaneously (98). In addition, waist
circumference and waist-to-hip ratio seem to require ethnic-specific cut-off points that
makes their use for screening complicated (102). Another anthropometric index, waist-to15

height ratio (WHtR) is a better predictor of central obesity-related outcomes as compared
to BMI and waist circumference (103). Thus, it has been suggested for use as a global
screening index with cut-off point 0.5.
Chronotype, social jetlag, and basic vital signs
Blood pressure (BP) has wide circadian variation determined by internal and
external factors. In healthy normotensive individuals blood pressure rises abruptly upon
waking up and is the highest in the morning, slightly decreases after meals and is the
lowest during night sleep (104). Blood pressure varies by sex; men usually have higher
BP and lower resting heart rate (HR) than women (104, 105). During the day, there are 2
BP peaks, at 9 a.m. and 7 p.m., and a slight nadir at 3 p.m. The internal or circadian
regulation of BP and HR occurs via hormones, peptides and neurotransmitters which all
have their own circadian rhythms (104). External factors affecting blood pressure include
physical activity, diet and sleep (106). Evening chronotypes tend to have higher systolic
blood pressure and heart rate and lower heart rate variability than people with morning
chronotypes, whereas no significant difference was observed for diastolic blood pressure
(44, 105). In two studies, evening chronotypes had higher SBP and HR after being
exposed to stress (44, 105). Social jetlag may affect the cardiovascular system. For
instance, in a recent pilot study among rotating shift workers, social jetlag positively
correlated with resting HR (107). Larger longitudinal studies are needed to confirm those
relationships. Since chronotype and SJL have been associated with cardiovascular
pathology and type 2 diabetes (46, 49, 107), more research is needed to explore
relationships between chronotype/social jetlag with basic physiologic characteristics such
as BP and HR. This information may be useful in the future to develop lifestyle
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recommendations to prevent cardiovascular complications and type 2 diabetes in people
with different chronotypes.
Chronotype, mood and perceived stress
Little is known about relationships between chronotype and mental health.
Individuals with evening chronotype tend to have psychiatric conditions, such as major
depressive disorder, bipolar disorder, anxiety or addiction disorder, or insomnia, and their
depression symptoms are more severe (30-33, 108). It is difficult to make a conclusion
whether mental condition affects chronotype or vise versa due to the cross-sectional
nature of these studies (30, 31, 33, 57, 109). Studies in healthy individuals also revealed
that people with evening chronotypes were more likely to have depressive symptoms (3442, 110), experience higher level of stress (34, 43, 44, 111) and complain about poor
health (10, 34, 110). Healthy individuals with evening chronotypes were more likely to
have seasonal variation of mood and behavior and experience burnout, consume
stimulants, coffee, caffeinated soft drinks and alcohol, to smoke and to consume ‘fast
food’ than those with morning and neutral chronotypes (41, 53, 93, 110, 112, 113),
although not all studies support this observation (34). Some studies report that
morningness also may be associated with altered health (22, 45-47). For instance, people
with morning chronotypes have difficulty staying asleep in early morning hours and
report elevated morbidity elicited by Nottingham Health Profile questionnaire (45). In
one study, young people with morning chronotype had a higher lifetime risk of any of the
DSA IV Axis one disorders (e.g. major depressive episode, schizophrenic episode, panic
attack), although, people with evening preference had higher odds of having three and
more of those disorders (110). Morningness has been associated with a higher cortisol
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awakening response (48), and elevated systolic blood pressure, blood glucose, low
density lipoprotein and total cholesterol levels compared with evening types (46). Total
sleep deprivation for 24 hours in healthy people with a morning chronotype led to
increases in depression-dejection symptoms, whereas depression-dejection symptoms
decreased among evening chronotypes (50). This may help explain why people with
morning chronotypes have decreased tolerance to shift work, particularly to night shifts
(13, 14). They accumulate larger sleep debt, have lower quality of daytime sleep and
more likely to withdraw from shift work as compared with evening chronotypes (13, 14).
There is an evidence that the relationship between morningness-eveningness preference
and stress can be mediated by perceived sleep disruption (111), and the relationships
between chronotype and depression can be modified by BMI (57). Thus, the role of
various other factors in the relationships between chronotype, perceived stress and altered
mood also should be taken into consideration.
Social jetlag and mood disorders
Studies of SJL and mood disorders indicate that SJL is associated with depression
and smoking (6, 37). Rural Brazilian residents with more than two hours of SJL had
higher depression scores compared to those with two hours or less (37). However, in
another study SJL was not associated with depression (36). It is possible, that SJL, rather
than chronotype, predisposes to depressive mood as it has been shown for smoking (6).
Social jetlag strongly correlates with chronotype (6, 12, 37, 49), and there is some
evidence suggesting that the relationships between SJL or sleep deprivation and
depressive mood may be driven by chronotype (37, 50). For instance, rural Brazilian
residents with up to two hours of SJL ranked by their mean depression scores from the
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highest to lowest in the following order: intermediate, morning and evening chronotypes
(37). The mean depression scores for two other groups of larger SJL (>2-4 and >4 hours)
were not presented due to the small sample size, and SJL-depression relationship was
statistically significant only among people with ≤ 2 hours of SJL (37). In agreement, in
an experimental study among healthy people following 24 hours of sleep deprivation,
depression-dejection symptoms increased among people with morning chronotypes and
significantly decreased in those with evening chronotypes (50). After partial sleep
deprivation (participants went to bed at their regular time and were awoken at 1:30 AM),
depression-dejection scores in morning chronotypes did not significantly change while in
evening chronotypes they decreased (50).
Temporal patterns of sleep characteristics
There is a multitude of sleep disorders and the most common of them is insomnia
(114); thus, it will be used as an example of “disrupted” or “bad sleep”. The proposed
study, however, will not be limited to insomnia. Insomnia is can be defined as difficulty
falling asleep, staying asleep, or decreased sleep quality despite having opportunities for
sleep with the following day time impairment (115). Because different epidemiological
studies define insomnia different ways, the prevalence of insomnia symptoms and
insomnia diagnosis varies between studies and populations (116). The prevalence of
insomnia symptoms in adults is 33-50% and the prevalence of general insomnia disorder
(insomnia symptoms associated with associated functional impairment) is 10-15% (115).
Studies show that insomnia may be associated with increased risk of many chronic
diseases such as cardiovascular disease (117), hypertension (118), obesity (54, 119),
diabetes (120), and cancer (28, 121, 122). Taking into account high prevalence of
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insomnia in general population, investigation of its role in development of chronic
diseases is very important. Recently, relationships between sleep characteristics and
previously mentioned highly prevalent chronic diseases have been examined in many
prospective studies (59-65). In most of these studies, information about sleep was
obtained from questionnaires completed by study participants who were asked to provide
average estimates for previous time periods of different length. Thus, these studies
assume that self-report accurately describes the individual's sleep and sleep
characteristics do not change over time. On the contrary, it has been shown that sleep
disruption assessed by self-report differs from sleep assessed using objective measures
(123, 124). For instance, healthy young individuals in one study overestimated their sleep
onset latency and underestimated frequency of awakening (124). In another study,
participants with chronic insomnia underestimated their total sleep time and number of
awakenings but overestimated sleep onset latency (125). Only a few studies have
investigated the variability of sleep characteristics over prolong periods of time using
objective measures such as polysomnography or actigraphy (66-68). In middle-aged
people, sleep measures, such as sleep duration, efficiency, latency and time in bed
showed considerable day-to-day variability, however, they were stable during the 1-3
year follow-up (66-68). In college students aged 18-40 years, longitudinal studies
assessed sleep based only on self-report and yielded contradictory results; both studies
were conducted during the spring semester (126, 127). Among undergraduate students,
for instance, sleep duration decreased and the number of awakenings increased as the
semester progressed (126). In another study, however, the sleep duration and quality
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increased within a 3-month long semester (127). Thus, a prospective study design is
proposed to study the consistency of actigraphic sleep measures over time.

Diet, sleep, physical activity, and prostate cancer
Chronic inflammation predisposes individuals to many chronic diseases,
including cancer, and may contribute to development of more aggressive form of the
disease (128, 129). Among agents predisposing to chronic inflammation are infections,
poor diet, disrupted or insufficient sleep, obesity, smoking and immunosenescence, or
age-related diminution of immune response (130-133). Continuous exposure to antigenic
stimulation and stress compromises the ability of the aging immune system to cope with
such stimuli, which in turn leads to chronic inflammation, the so-called “inflamm-aging”
(134).
The role of inflammation in carcinogenesis has been described for several
cancers, such as colorectal, lung, liver, bladder, cervical and pancreatic (135).
Additionally, a relationship with inflammation has been suggested for prostate cancer
(136, 137). Inflammation is frequently detected in different prostatic conditions, such as
prostatitis, benign prostatic hypertrophy, and prostatic intraepithelial atrophy (138-140).
On average, 11-16% of men in the United States are diagnosed with prostatitis in their
lifetime (141). About 20% of men with inflammation detected during prostate biopsies
developed prostate cancer within 5 years, and additional 6% were diagnosed with highgrade prostatic epithelial neoplasia, which is considered a precursor of prostatic
adenocarcinoma (136).
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There is evidence that inflammation within the prostate is strongly associated with
oxidative stress, which has been shown by multiple experimental, epidemiological and
clinical studies to play an important role in the pathogenesis of prostate cancer (142).
Inflammatory cells present at the sites of chronic prostate inflammation produce
increased amounts of reactive oxygen species (ROS) (143) that, over time, cause DNA
mutations, promote genetic instability and cellular senescence and, therefore, can
contribute to the initiation of carcinogenesis (144). In addition, prostate cancer cells
themselves produce high quantities of ROS, which can play important role in tumor
growth and development of a malignant phenotype (145). Increased levels of ROS
combined with inability of antioxidant systems to neutralize them lead to chronic state of
oxidative stress (146). Oxidative stress that occurs via tissue damage and the
corresponding recruitment of more inflammatory cells lead to the perpetuation of chronic
inflammation, which completes the vicious cycle (147).
Recent research identified a few modifiable risk factors - diet, physical activity
and sleep duration and disruption that have been shown to affect inflammation, immune
response and oxidative stress (28, 69, 70); however, further research is needed to
elucidate the role of these factors in pathogenesis of prostate cancer. Taking into account
the high incidence of prostate cancer in Western countries, developing strategies that
target these potentially modifiable risk factors is a high priority for public health. In the
United States, prostate cancer incidence and mortality rates vary by race and are the
highest among African-Americans (72, 73). According to age-adjusted estimates for
2013, prostate cancer incidence in African Americans is 70% and mortality is 2.4 times
higher than in European Americans (72, 73). African Americans tend to be diagnosed at a
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younger age and with more aggressive disease than their European-American
counterparts. Prostate cancer incidence and mortality in Hispanics/Latino and AsianAmericans are lower than in African- and European Americans (73). Migrant studies
show that prostate cancer incidence and mortality in immigrants to the United States are
higher than in their countries of origin which suggests the involvement of environmental,
behavioral and lifestyle factors (74, 75).
It has been proposed that racial/ethnic disparities in health status may be due to
differences in access to healthcare, socioeconomic status, cultural factors (e.g. diet,
utilization of health care, religious beliefs) and genetic predisposition (73, 148); thus, it is
important to explore complex relationships between multiple modifiable risk factors and
prostate cancer risk/aggressiveness by race/ethnicity. It has been shown, that racial/ethnic
minorities are more likely to have a sedentary life style and a bad diet with low
consumption of fruit and vegetables as compared to non-Hispanic Whites, and this
lifestyle pattern is associated with high levels of systemic inflammation, as expressed by
increased levels of C-reactive protein (CRP) (149-151).
Among the dietary factors that have been proposed to decrease prostate cancer
risk are tomatoes and lycopene, cruciferous vegetables, green tea, soy, vitamin E, and
selenium (152-154). The protective effects of selenium and vitamin E intakes, however,
were not confirmed in a recent double-blind placebo-controlled Selenium and Vitamin E
Cancer Prevention Trial (SELECT study) (155). The potential mechanism of anticancer
effect of plants mentioned above and vitamin E works through protection of cells and
DNA from oxidative stress (156). Phytochemicals contained in cruciferous vegetables,
kale, cauliflower and Brussels sprouts, in addition to antioxidative, also have pro23

apoptotic (157), anti-proliferative and anti-metastatic effects in prostate cancer cells in
vitro, and in animal models (158). Excessive intake of total dietary energy, meat, dairy
products, calcium, total and animal fat, and beta-carotene, on the contrary, may
predispose to increased prostate cancer risk (152-154). According to some theories,
excessive intake of fat and red meat can promote carcinogenesis within the prostate via
increased insulin growth factor (IGF) and damage by ROS (156). Caloric restriction
reduces oxidative stress and related damage in vitro and in animal models (159).
Although analyses of single nutrients and foods are a common practice, they are
inherently flawed because they do not account for possible interactions between nutrients
and fail to evaluate joint effects of diet on health outcome (76). More recent approaches
use diet quality scores and dietary patterns to evaluate a combined effect of food usually
consumed on disease (77). For instance, higher Healthy Eating Index and Alternate
Healthy Eating Index-2010 values were associated with decreased risk of total prostate
cancer, while no association was detected for the alternate Mediterranean Diet score (78).
A few studies examined relationships between dietary patterns and prostate cancer and
yielded inconsistent results (76, 79). The use of diet quality scores and dietary patterns
has inherent shortcomings. For instance, the diet quality scores only measure adherence
to the recommended diet and fail to account for ethnic variability within and between
populations (77). Dietary pattern analysis lacks standardization, which impairs
generalization, complicates comparisons between studies and is more suitable for
hypothesis generation rather than testing (77).
Developed by researchers at the University of South Carolina’s Cancer Prevention
and Control Program, the dietary inflammatory index (DII) is a unique approach which
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allows for calculation of the overall inflammatory score of the individual’s diet from
maximally anti- to maximally pro-inflammatory. More negative scores are associated
with anti-inflammatory potential, whereas more positive scores are indicative of more
pro-inflammatory potential (80, 160). The major advantage of DII over other dietary
indices is that it measures the inflammatory potential of the individual’s diet based on
actual intakes. The individual’s DII scores are standardized against range of actual food
intakes observed in 11 different populations around the world, which facilitates
comparability between existing and future studies (160). Another important advantage of
the DII is that it gives comparable results if calculated using different methods of dietary
assessment, which facilitates its use by epidemiological studies of different design and
different dietary assessment methods (161). DII scores have been shown to predict levels
of inflammatory markers and risk of chronic disease in several studies (80, 82, 161-180).
Several of these studies investigated the relationships between DII and breast,
esophageal, pancreatic, and colorectal cancers (164-166, 174, 180). One case-control
study has investigated the relationships between DII and prostate cancer risk among
Jamaican men (181). Men in the highest quartile of DII score had 2.4 times increased risk
of prostate cancer as compared to those in the lowest quartile (aOR=2.39; 95% CI:1.145.04). This suggests that a diet with the higher proinflammatory potential may increase
individual’s risk of prostate cancer; however, this finding needs to be confirmed in
longitudinal studies with larger sample sizes that include participants of different
race/ethnicity.
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CHAPTER 3
Methods
Specific Aims 1 & 2
1. Study population
For Aims 1-2 was used previously collected data from the Energy Balance Study
(EBS) conducted by researchers from the University of South Carolina, Columbia, SC
(182). The EBS is an ongoing three-year longitudinal study investigating effects of
energy intake and expenditure on changes in body weight, body composition and health
indices in healthy young adults. In 2011, the EBS recruited 430 healthy men and women
who were 21-35 years of age and had a BMI of 20-35 kg/m2. This population group was
studied since they may be at risk for weight gain and an increase in body fat as they
approach middle age (183). The prospective participants were eligible for the study if
they were 21-35 years of age, did not have any major health conditions, did not change
their health behavior within preceding 6 months, and did not plan to relocate within the
next 15 months (182). The participants were excluded if they had history of major
depression, anxiety or panic disorder, took serotonin reuptake inhibitors, used
medications to lose weight or stop smoking within previous 6 months. Women were
excluded if they gave birth within previous 12 months, changed their birth control
regimen within the 3 previous months, were pregnant, or if they planned to start or stop
birth control medication within the following 3 months (182). All otherwise eligible
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prospective participants were excluded if they had systolic blood pressure ≥150 mmHg
and/or diastolic blood pressure ≥90 mmHg or a blood glucose level >145 mg/dl as
diagnostic criteria for hypertension and diabetes, respectively. The EBS was approved by
the Institutional Review Board at the University of South Carolina, and all study
participants signed informed consent.
2. Energy Balance Study data collection procedures
The participants were initially screened for demographic and health-related
inclusion/exclusion criteria via email and then additionally screened over the phone. All
eligible study participants attended an orientation session where they were provided the
information about the study and had their height and weight measured to verify their
BMI. Within three weeks following the orientation, the participants had three baseline
measurement sessions. During the first baseline session the participants provided detailed
demographic information and a medical history and completed psychometric and activity
questionnaires. Resting blood pressure, weight, height, hip and waist circumferences, and
body composition were measured during the second baseline session. For the third
baseline session, the participants had to fast for 12 hours and to abstain from physical
activity for 24 hours. During this session weight, height, hip and waist circumferences
were measured again, and the participants received a SenseWear® Mini Armband (SWA)
(BodyMedia Inc., Pittsburgh, PA) to monitor their physical activity and sleep over 10
days (182). During these 10 days, licensed dietitians conducted three 24-hour dietary
recalls by phone; two on randomly selected week days and one on a weekend. These
dietary recalls elicited information about all the food participants consumed during the
previous 24 hours. The follow-up assessments were conducted quarterly up to 24 months.
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Upon completion of all follow-up sessions the study participants were given incentives:
$500 and a report containing the information on their energy intake and expenditure,
body weight and composition, resting metabolic rate, and cardio-respiratory fitness
levels.
3. Sleep measures
The sleep measures were derived from the Armband data. The SenseWear® Mini
Armband is a portable device 8.8×5.6×2.1 cm in size, 82 g weight, worn over the triceps
muscle of the right arm and has micro-electro-mechanical sensor detecting and measuring
limb movements (184). The sensor is monitored 32 times per second and data were
recorded at 1 minute intervals. The SWA data by minute are analyzed using SenseWear
Professional® Research Software (Version 7.0, Body Media® Inc.). The demographic
information (i.e. age, sex, height, weight and smoking status) was used to customize
proprietary algorithms. The SWA data yields several average night-time sleep measures:
sleep onset and wake-up times, TST, SOL, WASO, and SE (185). The sleep onset time
was determined by the first out of three minutes asleep that coincided with ≥10 minutes
lying down (185). Morning wake-up time was defined by the first out of 90 consecutive
minutes awake (185). Sleep duration is the sum of all minutes asleep during one sleep
bout (185). The ability of the SWA to measure sleep was validated against
polysomnography and found to be adequate (184). For each study participant all
measures were averaged across the entire period of wearing of the SWA (4-10 days).
Day-to-day variability in sleep characteristics exceeded the long term variability (68).
Previous studies showed that five to seven nights of actigraphy are sufficient to obtain
reliable estimates of sleep duration (68, 123, 186). The study participants were instructed
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to take the Armband off only when it could get wet (showering or bathing) and to keep a
log of their activities during all times when the Armband was not worn (182). Activities
from the log were matched to activities in the 2011 Compendium of Physical Activity
(187), and corresponding metabolic equivalent was multiplied by individual’s resting
metabolic rate which allowed to calculate energy expenditure and sleep characteristics
during non-wear periods (182). Total physical activity minutes were calculated for
activities equal to or exceeding 1.5 metabolic equivalents (185). Physical activity was
used as a continuous measure. Only observations with actigraphy data on 4 or more
nights were considered complete and used in this study.
3.1. Chronotype
Chronotype was defined as the time of mid-sleep on work days corrected for
“make-up sleep” on free days (12). For detailed chronotype calculations see Appendix A.
3.2. Social jetlag
SJL was defined as a difference between midpoints of sleep on a weekend
(unadjusted) and on week days (12). An absolute value of the social jetlag was used for
all analyses where SJL was an independent variable.
3.3. Total Sleep Time
TST was categorized as <6, 6-7, and ≥7 h (185). Two sleep duration measures
were used for all analyses: average for all days of actigraphy (week days and weekend
days) and average on week days only. The upper cut-off point 7 h was selected due to the
insufficient sample size that we would have if we selected cut-off point ≥8 h, which is
frequently used in other studies (96, 119, 188). Moreover, several studies showed that
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individuals tend to overestimate their average sleep duration by 1 hour and more as
compared with objective measures (e.g. actigraphy) (189, 190).
3.4. Sleep onset latency
SOL is a time that a person spends in bed before he/she falls asleep. In EB study,
sleep onset latency was calculated using SWA data as time between lying down and sleep
onset (185). According with clinical guidelines, sleep onset latency of >30 min is
considered one of the symptoms of insomnia (115). However, in the EBS population, less
than 5% of participants had sleep onset latency >30 min at any one of five time points.
Thus, the more relaxed cut-off point of 12 min ( ≥12 vs. <12 min) was used (191).
3.5. Wake After Sleep Onset
WASO was calculated from SWA data as a sum of wake periods of ≥2 min each
after sleep onset and until the final wake-up time (185). To be consistent with the
previous studies that used wrist actigraphy, WASO was dichotomized (<60 min, ≥60
min) (119, 188).
3.6. Sleep efficiency
SE was calculated as a proportion of TST from the length of the night sleep bout
(185). Naps were excluded. SE was used as a continuous and a categorical variable; the
latter was dichotomized according with clinical guidelines for insomnia (≥85% vs. <85%)
(115).
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3.7. Naps
Naps were defined as sleep bouts <4 hours that ended between noon and 10 p.m.
or bouts <45 minutes (185). Variable nap was dichotomous (Yes/No); those with >0 min
of nap were consider having a nap.
3.8. Sleep quality
Sleep quality was defined using Pittsburgh Sleep Quality Index (PSQI) obtained
using PSQI questionnaire (see section "Questionnaires"). The PSQI score was
dichotomized using conventional definitions of poor sleep (PSQI >5) and a good sleep
(PSQI ≤5) (192). TST, SOL, WASO or SE were used as indicators of sleep disruption.
Sleep measures in this study had potential limitations. The assumption that the
study participants had free days only on weekends may introduce non-differential
misclassification of the exposures: chronotype and social jetlag. To address this issue,
distributions of chronotype and social jetlag in the study population were compared with
the distributions among participants of the same age in other studies.
4. Questionnaires
4.1. Profile of Mood States (POMS)
POMS is a self-administered questionnaire that consists from 65 adjectives and
short phrases with Likert-type scale with five answer choices for each question (193).
Different groups of adjectives define six factors: Tension-Anxiety, Depression-Dejection,
Anger-Hostility, Vigor-Activity, Fatigue-Inertia, Confusion-Bewilderment, and each of
those factors has its own scale. The Total Mood Disturbance Score (TMD score) is
calculated by summing 5 factors and then subtracting for the Vigor-Activity score. The
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Total Mood Disturbance Score and its 6 components were used separately as continuous
variables. The Energy Balance study participants completed the POMS questionnaire at
baseline, 12 and 24 months follow-up (Table 2.1), and all 3 aforementioned time points
were used in the analyses.
4.2. Perceived Stress Scale
Perceived Stress Scale is a 10-item questionnaire where each item inquires how a
subject feels or thinks and offers him/her 5 choices with increasing value from never to
very often (194). The positive items are reverse scored. All scores are summed to yield
the total score ranging from 0 to 40. A higher score indicates a higher stress level. The
Perceived Stress Scale was validated in different populations, found to be a better
measure of overall stress as compared to objective measures of stressful life events, and
recommended for studies investigating relationships between stress and disease outcomes
(194-196). The Perceived Stress Score (PSS) was used as a stress measure at 3 time
points (baseline, 12 and 24 months follow-up) (Table 2.1). The Perceived Stress Scale is
not a clinical test; therefore, there are no established cut-off points. To categorize PSS,
some studies used a median split (194, 197) while others used quartiles (198). PSS in the
EBS sample had approximately normal distribution and was modeled as continuous and
categorical variables with the median as a cut-off point (<12 vs. ≥12).
4.3. Pittsburgh Sleep Quality Index (PSQI)
PSQI ascertains information on seven areas of sleep during the previous month
(192). The respondents self-score each of the seven components using a Likert scale from
0 to 3, where 3 is assigned to the highest negative extreme. The sum of scores for all
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individual components yields the total PSQI score (192). It was administered at baseline,
12 and 24 months follow-up (Table 2.1). The PSQI was used as an indicator of sleep
quality: poor sleep (PSQI >5), and a good sleep (PSQI ≤5) (192).
5. Anthropometric measures
For the assessment of all anthropometric measurements the participants were
dressed in scrubs and had bare feet. Their height and weight were measured using
traditional stadiometer and electronic scales with a precision of 0.1 cm and 0.1 kg,
respectively. The average of three measurements was used to calculate BMI (weight
(kg)/height (m2) ). To measure waist and hip circumferences, a calibrated spring-loaded
tape measure was used. The waist circumference was measured at mid-point between
costal margin and iliac crest on the axillary line on both sides of the trunk and 2 cm above
the umbilicus (182). The hip circumference was measured at the level of the greater
trochanter, at the widest point. The average of three measurements rounded to 0.1 cm was
recorded. Body composition was measured using dual x-ray absorptiometry full body
Lunar fan-beam scanner (GE Healthcare model 8743, Waukesha, WI).
BMI was categorized into two groups: underweight and normal weight (<25
kg/m2); overweight and obese (≥25 kg/m2) (199). BF% was dichotomized using the
guidelines by the American Society of Bariatric Physicians (ASBP) and American
Medical Association (AMA) specialty board (2009) that defined obesity as BF% ≥25% in
men and ≥30% in women (98). A recent meta-analysis showed that cut-off points for
BF% >25% in men in > 30% in women were the most sensitive for obesity (99). Waistto-hip ratio will be dichotomized: <0.95 vs. ≥0.95 in men and <0.80 vs. ≥0.80 in women
(200). Waist-to-height ratio will be dichotomized as <0.5 vs. ≥0.5 (103). An average of
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two resting blood pressure measurements were categorized into two groups: SBP ≥120
vs. <120 mmHg, and DBP ≥ 80 vs.<80 mmHg.
6. Covariates
Estimates of total daily physical activity time were obtained from armband data.
Information for the periods of non-wear was supplemented with values for matching
activity from the 2011 Compendium of Physical Activity (184). Total daily hours of
physical activity were defined as any activity of at least 5 metabolic equivalents. Time
napping was obtained from armband data. Dietary information was collected using three
24-hour dietary recalls conducted by phone; two on randomly selected weekdays and one
on a weekend. The Nutrient Data System for Research (version 2012: Nutrition
Coordinating Center, University of Minnesota, Minneapolis, Minnesota) was used to
estimate nutrient and individual food intakes from the dietary recalls. Forty three food
parameters and nutrients were further used to calculate a dietary inflammatory index (eDII) that expresses an inflammatory potential of individual's diet (81). Lower DII scores
are anti-inflammatory while the higher scores are more proinflammatory, and the
maximum theoretical range is −8.87 to 7.98. To account for individual differences in
energy intake, the DII scores were calculated per 1,000 kilocalories (4,184 KJ) (e-DII) as
previously described (185).
7. Exclusion criteria
All 430 participants of the EBS were eligible for the proposed study. Individuals
were excluded from statistical analyses if their armband data had the following
deficiencies: missing bed time or wake time, <4 days of actigraphy in any given
assessment period, missing sleep data on the weekend, extreme or implausible TST
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values (<4 hours either on week days, free days, or on average, TST >11 hours on work
days or on average), and when mid-sleep on free days occurred in the afternoon (12). In
addition, participants were excluded from all analyses if they regularly used (≥3 times per
week) sleep promoting medications (over the counter or prescription), worked night
shifts, or traveled across meridians during periods of armband wear. The final analytical
dataset consisted of 390 participants (1,431 repeated observations).
7. Statistical analyses plan
Specific Aim 1
The first specific aim was to determine whether chronotype, social jetlag, and
sleep disruption change within two years. For these analyses was used SWA data at five
time points (baseline, 6, 12, 18, and 24 months). The analytical dataset consisted of 390
participants (1,431 repeated observations).
Regression approach
First, descriptive statistics, distributions for continuous data and frequencies for
categorical variables were analyzed. Further, the bivariate relationships between time,
chronotype, SJL, objective sleep measures (TST, SOL, WASO, SE), and potential
covariates were explored using simple subject-specific Generalized Liner Mixed Models
(GLMM) with GLIMMIX procedure in SAS® (version 9.4, Cary, NC). This method
accounts for correlations between repeated measurements through the inclusion of an
additional variance component (201). Each subject in this study was considered a cluster
of observations. The following covariates were considered: sex (male, female), race
(European American [EA], African American [AA], Other [Hispanic, Asian, Native
American or mixed race]), education (high school graduate/GED some college, college ≥
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4 y.), income (<$20,000, 20,000 to <40,000, 40,000 to <60,000, 60,000 to <80,000,
≥80,000), employment (student/other, employed and self employed), marital status
(married, single), having children (yes/no), physical activity (h), caffeine intake (g/d), eDII, napping (yes/no), and season (winter [November-January], spring [February-April],
summer [May-July], autumn [August-October]), and current dieting (yes/no). Potential
covariates with p-value <0.2 in bivariate analyses were selected for inclusion in full
statistical models. Time was the main independent variable for all analyses. Separate
multivariable statistical models were built for chronotype, SJL and objective sleep
measures (TST, SOL, WASO, SE) as continuous dependent variables. Manual backwards
elimination was used to identify covariates for inclusion in the final model that changed
the effect estimate of the main exposure variable by ±10%. Variables that were
statistically significant (p≤0.05) also were included in the final model.
Latent class analyses
RMLCA was performed using PROC TRAJ in SAS® to identify latent groups for
each continuous variable (absolute SJL, chronotype, TST, SOL, SE, WASO) (202, 203).
This procedure uses a mixture model approach to define the trajectories of unique
subgroups within a population that don't change their group membership over time (204,
205). The best fitting crude model was selected using Bayesian Information Criterion and
comparing differences between simple and more complex models (205). The final
selection of the number of latent groups was based on the best model fit and minimum
group sizes containing ≥10% of the study population. Analyses for chronotype, TST and
SE were adjusted for race (EA vs. AA or Other) and sex, which were assumed not to
change over time. WASO was adjusted for race only. Absolute SJL and SOL were not
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adjusted for race or sex because latent groups were not influenced by these variables.
Since the group trajectories for each measure were linear, potential covariates that change
over time were not examined. Only participants with at least three assessments during the
study period were included into these analyses (n=312, 1,297 observations).
Finally, bivariate GLMM were used to identify demographic and other
characteristics that differed among the latent classes for absolute SJL and each of the
sleep outcomes.
Specific aim 2
The second specific aim was to examine the relationships between chronotype,
absolute SJL, objective sleep characteristics and various outcomes: BMI, %BF, WHR,
WHtR, blood pressure, mood, perceived stress, and poor sleep (defined with PSQI). For
the analyses involving anthropometric outcomes was used dataset with five time points
(n=390, 1,431 repeated observations). Since data on mood, stress and poor sleep was
available only for three time points (baseline, 12, and 24 months) a smaller subset of data
was used (n=390, 813 observations) for these analyses.
Descriptive analyses were conducted first. They included analyses of distributions
for continuous and frequencies for categorical variables. Bivariate associations between
chronotype, SJL, objective sleep measures, mood, perceived stress, poor sleep, and
potential covariates (see specific aim 1 above) were explored next using GLMM with
repeated measures. Potential covariates with p-value <0.2 in bivariate analyses were
selected for inclusion in full statistical models. Manual backwards elimination was used
to identify covariates for inclusion in the final model that changed the effect estimate of
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the main exposure variable by ±10%. Variables that were statistically significant (p≤0.05)
also were included in the final model. When examining relationships between SJL or
sleep measures and the anthropometric outcomes, mood and stress, chronotype
(continuous) was considered as a potential confounder along with other covariates.
RMLCA analyses using PROC TRAJ in SAS® were used to identify three latent
groups for chronotype as was described above. Any time points with complete SWA data
were included into these analyses. Since the group trajectories for all three latent
chronotype groups (morning, intermediate and evening) were linear, other potential
covariates that change over time were not used to adjust trajectories. Adjusted means of
SJL and all objective sleep characteristics by latent chronotype group were compared
using F-test with PROC GLIMMIX. The intermediate chronotype was used as a
reference group. This categorical chronotype variable was used as a main independent
variable in the GLMM evaluating the relationships between chronotype and
anthropometric measures. To explore a possibility that the relationship between SJL,
other sleep characteristics and anthropometric measures were modified by chronotype,
two approaches were used. First, an interaction term between a sleep measure and
chronotype group were added to the final statistical model. The second approach
involved stratification by chronotype group. This approach was also applied in the
analyses of the relationships between absolute SJL, mood and stress.
Specific Aim 3
1. Study population
For the proposed study was used data from the California Men’s Health Study
(CMHS), a large multiethnic cohort of U.S. men members of Kaiser Permanente (KP), a
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health insurance provider that covers a large number of residents of Northern and
Southern California. The primary goal of CMHS cohort was to study the etiology of
prostate cancer in populations with diverse ethnicity (206). In 2002-2003 the CMHS
recruited 84,170 men of ages 45-69 years; 40% of them were from minority populations.
Men were eligible for the CMHS if they had membership at KP for at least one year prior
to the recruitment and were 45-69 years of age. Information about the CMHS recruitment
and data collection procedures was described in detail elsewhere (206). Briefly, the study
enrolled minority populations including Chinese, Latino and African Americans. The
potentially eligible participants were first selected based on their last names obtained
from insurance records, and a preference was given to men with Chinese and Spanish last
names (206). The recruitment was conducted in three waves. First, the participants were
mailed a recruitment letter and a short questionnaire inquiring about their ethnicity,
anthropometrics, and a personal history of prostate specific antigen (PSA) screening,
benign prostatic hyperplasia (BP), and prostate cancer. The letters and questionnaires
mailed to men with Chinese last names were in Cantonese/English and in
Spanish/English for all others. Also, the participants were selected from areas covered by
KP plan where a high proportion of residents were African American (206). Further, men
who responded to the short questionnaire and were eligible for the study were mailed a
longer questionnaire. Some participants completed both short and long questionnaires online (206). The CHMS collected comprehensive information on participants' health
status, comorbidities, family history of prostate cancer, medication and supplementation
use, and potential prostate cancer risk factors such as diet, physical activity and sleep.
The CMHS cohort has broad range of education and income (206). The important
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advantage of enrolling study participants from among the members of the health
insurance plan allows linking self-reported data with medical records and information
from cancer registries. The latter provides high quality ascertainment of prostate cancer
cases.
For the proposed study was used data on 43,202 participants of the CMHS
followed from the time of the completion of the long CMHS questionnaire in 2002-2003.
Time of the follow-up was censored at: diagnosis of incident prostate cancer, death, gap
in KP membership exceeding 90 days, or the end of the study on December 31, 2014,
whichever comes first. For the description of the available study population see Table 7.
Participants who reported personal history of prostate and any other cancer except nonmelanoma skin cancer in the baseline questionnaire were excluded (100/1,286).
Participants who had caloric intake of less than 500 kcal or greater than 6,000 kcal per
day were excluded from the analyses (53 with prostate cancer and 905 without prostate
cancer). Indicator variables with consequent sensitivity analyses were used to preserve
observations with missing data on significant confounders. For the analysis of the
relationships between DII and the incidence of advanced prostate cancer, all participants
with missing data on prostate cancer stage based on SEER classification were excluded
(n=38, 1.36%).
2. Questionnaires used to collect the data in CMHS
2.1. Short questionnaire, as was previously mentioned, elicited information about
anthropometrics, and a personal history of PSA screening, BPH, and prostate cancer.
2.2. Long questionnaire was 24 pages long, completed upon enrollment and elicited
information on demographics, family history of cancer, an individual's health conditions
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including those involving prostate, medication use, lifestyle factors including physical
activity and smoking, diet and supplement use, marital status, education and family
income during the preceding year.
2.3. Semi-quantitative food frequency questionnaire (FFQ) was the version of
Women's Health Initiative FFQ modified for use in men and validated in several studies
(207-209). This FFQ allowed collecting the information about habitual diet and alcohol
consumption within the previous year. E-DII was calculated for all participants of this
study.
2.4. Physical activity questionnaire used questions adopted from the CARDIA Physical
Activity History (210). It elicited information on frequency, duration and intensity of
recreational, household and occupational activities (206). Total physical activity was
measured in MET-hours per week and used as a continuous variable for all analyses.
3. Prostate cancer ascertainment
The information about all prostate cancer cases diagnosed during the
follow-up was obtained via linkage of CMHS members to the Kaiser Permanente
Northern California Cancer Registry (206, 211). California state law requires reporting of
all incident cancer cases and the KPNCCR ascertains and reports all cases according to
the standards established by the National Cancer Institute’s Surveillance, Epidemiology,
and End Result Program (SEER). In this study, PrCA was categorized into three groups
using the updated (2010) version of the standard PrCA staging system endorsed by the
American Joint Committee on Cancer (AJCC)/International Union Against Cancer
(UICC) (212).
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4. Measures
Exposures
The DII was calculated per 1,000 kcal (e-DII) using derived values for 27 food
parameters including whole foods, micro- and macronutrients, and other food
constituents (e.g. flavonoids). The information on habitual food intake used for derivation
of the food parameters was elicited using previously mentioned semi-quantitative FFQ.
The choice of food parameters for the DII calculation is based on previous research that
entailed reading and scoring nearly 2,000 articles (160). Derived from the literature
individual effects of individual DII components were standardized to global database
comprised from 11 diverse populations: USA, Australia, Bahrain, Denmark, India, Japan,
Mexico, New Zealand, South Korea, Taiwan, and UK (81). This approach to calculation
of DII both “anchors” the individual’s exposure to a robust range of dietary patterns in a
variety of cultural traditions and obviates completely the problem of units because the zscores and percentiles are independent of the units of measurement (i.e., the percentile is
the same whether the parameter is expressed in ug or mg) (160). Ideally, the DII
calculations are based on the total 45 food parameters, although it also can be calculated
when fewer food parameters are available. For instance, the DII was previously used in
the SEASONS study with the 7DDR (which yielded 28 food parameters) and in the
Asclepios Study using semi-quantitative FFQ (which yielded 17 food parameters) and
had observed findings consistent with those obtained from 24-hour recall interviews
(which ideally yield all 45 parameters) (83, 169). From the research conducted this far,
the DII is typically within the range of -5 to +5 (maximum and minimum ~-8 and +8). In
the sample available for this study, the DII in all participants ranges from -6.3 to 4.7
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(Table 7). The reason for the adjustment for energy is previously detected strong negative
correlation of the DII with total energy intake (164). An absolute intake of each food
parameter in the study population was individually modeled using a regression model
with total caloric intake in the study population as an independent variable as previously
described (164). The predicted energy-adjusted intake of each nutrient was calculated as
a sum of the absolute nutrient intake of an individual with the mean caloric intake with
the corresponding residual from the regression model. Further, energy-adjusted intakes of
all individual food parameters were standardized to the world’s population using z-scores
and percentile scores. The individual percentile scores were then multiplied by
parameter-specific inflammatory values and summed yielding the final e-DII score. For
all analyses, the e-DII will be used both as a continuous variable and as a categorical
variable. Since the clinically meaningful cut-points for e-DII have not yet been
established, we will use the cut-off points between quartiles of e-DII distribution among
men without prostate cancer.
Events of interest
For the analyses of the relationship between e-DII and PrCA risk (sub-aim 1),
incident PrCA will be presented as a dichotomous variable (Yes/No). For the sub-aim 2,
PrCA was categorized into three groups using the updated (2010) version of the standard
PrCA staging system endorsed by the American Joint Committee on
Cancer (AJCC)/International Union Against Cancer (UICC) (212). The high-risk PrCA
group included men with clinically localized high-risk PrCA and advanced, very highrisk PrCA (≥T3a or PSA>20 ng/ml, or a Gleason score of 8-10, or those who died from
PrCA). The clinically localized, intermediate-risk group consisted of men with T2b-T2c,
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or T1-T2a and PSA10-20, or T1-T2a and a Gleason score of 7. All other men with PrCA
were in the clinically localized, low-risk PrCA group.
Statistical analysis
The follow-up time was censored at: diagnosis of incident PrCA, death, gap in KP
membership exceeding 90 days, or the end of the study (December 31, 2014), whichever
came first. The analyses started with descriptive statistics. The e-DII was categorized into
quartiles based on its distribution among all participants. Categorical variables with strata
containing <10% of the total population were recoded using indicator variables that had
missing values as a separate category. Bivariate relationships between prostate cancer
status and e-DII, or potential covariates, including: race (White, Black, Asian, Hispanic,
Other), age at baseline (5-year intervals for the overall PrCA risk estimates and 45-55,
56-65, 65-70 years for subgroup analyses), body mass index (BMI) calculated from selfreported weight in kilograms divided by square height in meters (< 25, 25-29.9, ≥30
kg/m2), education (high school equivalent or less; vocational or technical school; some
college, associate or bachelor degree; graduate/professional school), smoking status
(current or former smokers vs. non-smoker), income (<$40,000, $40,000-$59,000, $60$80,000, $80-100,000, >$100,000), regular use of non-steroidal anti inflammatory
medicines (NSAID) (Yes/No), regular multivitamin use (Yes/No), sleep duration (≤6, 7,
≥8 hrs), total physical activity (0-359, 360-1102, 1103-2201, > 2202 MET-min/week),
history of diabetes (Yes/No; recorded diagnosis in the Northern California KP Diabetes
Registry), family history of PrCA in a first-degree relative (Yes/No), and benign prostatic
hyperplasia (BPH).Variables with a p-value of ≤0.20 will be selected for further
evaluation in a multivariable model. A manual backwards selection procedure was used
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to identify covariates for inclusion in multivariable models. Variables were retained in
the final statistical models if their exclusion resulted in a change in the effect estimate for
e-DII by ≥10%. Statistically significant covariates (α<0.05) also were retained in the final
statistical models. The proportional hazards assumption was tested using graphical
(Kaplan-Meyer survival plots) and regression approaches (cumulative Martingale
residuals). Effect modification was tested using two approaches: Likelihood Ratio Test
(LRT) for significance of the interaction term added to the final model, and stratification
of the analysis based on differing levels of the effect modifier. Cox proportional hazards
models were used to assess the relationships between the e-DII and either high- or
intermediate-risk PrCA. The proportional hazards assumption was violated for sleep and
age; therefore, these variables were placed in the STRATA statement in the PHREG
procedure in SAS®. For linear trend tests, the median of each e-DII quartile was included
in statistical models as a continuous variable with adjustment for the same confounders
that were included in the previous analyses.
Sensitivity analyses were conducted to explore the possible effects of missing
data on the results. Men diagnosed with PrCA during the first 3 years of follow-up were
excluded in order to assess the possibility of reverse causality. In separate analyses, all
participants with missing sleep duration were excluded, and analyses were then repeated
after removal of the sleep duration variable from the statistical models.
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Table 3.1 Questionnaires and measurements used in the Energy Balance Study
Time point
Questionnaire/
measure
Baseline
6M
12 M
18 M
24 M
Demographics



Medical History

Profile of Mood States1



Perceived Stress Scale



PSQI



Physical Activity





Sleep measures





Anthropometrics2





Basic vital signs3





PSQI: Pittsburgh Sleep Quality Index (PSQI).
1
Yields Total Mood Disturbance Score (TMD).
2
Height and weight, waist circumference, hip circumference, percent total fat mass, percent
total lean mass.
3
Resting heart rate, systolic blood pressure, diastolic blood pressure.
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CHAPTER 4

Stability of Social Jetlag and Sleep Characteristics Over Time: A Prospective Study1

1

McMahon, D.M., Burch, J., Wirth, M.D., Youngstedt, S.D., Hardin, J.W., Hurley, T.G.,
Blair, S.N., Hand, G.A., Shook, R.P., Drenowatz, C., Hebert, J.R. To be submitted to
Chronobiology International.
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ABSTRACT
Background: Insufficient sleep has been associated with increased risk of many chronic
diseases that can take decades to develop. However, few studies have examined the
persistence of sleep disruption over time. Armband actigraphy is an objective method of
monitoring of an individual's limb movements that yields sleep timing on work and free
days, and their difference defines ‘social jetlag’, a misalignment between internal and
social clocks. This prospective investigation examined objectively measured individual
sleep characteristics over a two-year period to test the hypothesis that SJL and poor sleep
remain stable during this time period.
Methods: Social jetlag [SJL] and sleep measures (total sleep time [TST], sleep onset
latency [SOL], wake after sleep onset [WASO]), sleep efficiency [SE]), were derived
from physical activity personal armband monitoring among 390 healthy men and women
21-35 years old. Participants wore the armband for a 4-10 day period at 6-month intervals
(N=1,431 person-weeks of sleep measurement). The consistency of sleep measures over
time was analyzed using generalized linear mixed models (GLMM) for repeated
measures. Repeated measures latent class analyses (RMLCA) were then used to identify
subgroups among the study participants with adequate or inadequate sleep characteristics
over time. These latent groups were then evaluated using GLMM to characterize
demographic or other personal characteristics that differed among the subgroups.
Results: Minor changes in mean SJL, chronotype, or TST were observed over time, and
no changes in SOL, WASO, or SE were observed during the study period. The RMLCA
identified two groups of absolute SJL: low (mean±SE: 0.8±0.6 h, 58%) and high
(1.4±0.8, 42%); those with high SJL were employed and had an evening chronotype.
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Similarly, two distinct subgroups were observed for SOL, WASO, and SE, with one
group consistently exhibiting disrupted sleep over time, and another with a relatively
normal sleep pattern; both remaining stable over time. TST had three latent groups with
relatively short (5.6±1.0 h, 21%), intermediate (6.5±1.0, 44%) and long (7.3±1.0 h, 36%)
durations, all with temporally stable linear trajectories. Subgroups with poor sleep tended
to be male, African American, have a lower income, and an evening chronotype relative
to those with more normal sleep characteristics.
Conclusions: Objective sleep measures in young adults remained relatively stable over
the two-year study period. Sleep disruption symptoms as measured by TST, SOL, WASO
and SE, persisted throughout the study. The results suggest that poor sleep can be a
chronic condition in certain subgroups, consistent with evidence that sleep disruption
contributes to metabolic syndrome, cardiovascular disease, cancer, and other chronic
disease risks.

Introduction
Insufficient sleep has been associated with increased risk of major chronic
diseases such as cardiovascular disease and hypertension (65, 118), obesity (213),
diabetes (120, 214), and cancer (28, 47). The biological processes associated with these
impacts may include immunologic, metabolic, and genetic factors (49, 52, 91, 95, 133,
215-217). In order to elicit pathophysiological changes that can lead to chronic disease,
sleep has to be disrupted over an extended period of time. However, the temporality of
sleep disruption has not been extensively studied. In many longitudinal studies,
information about sleep is only obtained at baseline by means of questionnaires, and it is
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assumed that self-reported symptoms accurately describe an individual's sleep
disturbances, and that they persist over time. However, sleep disruption assessed by selfreport can differ from sleep assessed using objective measures (123, 124). For instance,
one study among healthy young individuals reported that sleep onset latency was
overestimated and frequency of awakening was underestimated using self-reported data
(124). In another study, participants with chronic insomnia underestimated their total
sleep time and number of awakenings but overestimated sleep onset latency (125).
Several longitudinal studies assessed consistency of insomnia and sleep disruption over
various periods of time spanning from several months to 20 years (66, 67, 218-226).
Presence of insomnia and its subtypes was variable within one year of follow-up (226,
227). Studies with a follow-up of several years showed that insomnia is a fairly persistent
condition (66, 67, 218-223, 225), although its patterns may change over time and clinical
course of insomnia can exhibit remissions and recurrences (219, 224, 226).
Characterizing factors that contribute to the persistence of sleep disruption is important
for understanding its role as a chronic disease risk factor.
Only a few studies have investigated the variability of sleep characteristics over
prolong periods of time used objective measures such as polysomnography or actigraphy
(66-68, 225). In middle-aged people, objective sleep measures, such as sleep duration,
efficiency, latency and time in bed showed considerable day-to-day variability, although
they were stable during a 1-3 year follow-up (66-68, 225). No comparable studies
utilizing objective sleep measures have been conducted among young adults. The
importance of such investigations in young adults is based on a high prevalence of
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insomnia in the general population and a common knowledge that many chronic diseases
that manifest in middle age can take decades to develop.
Most human physiological processes and behaviors exhibit a circadian rhythm (1,
2). Due to variations in intrinsic timing, individuals may be categorized into morning,
neutral, or evening chronotypes (3, 4). People with morning chronotypes, the so-called
"larks", wake up and go to bed relatively early (between 10 p.m. and midnight), whereas
evening chronotypes ("owls"), prefer to wake up and go to bed late (between 1 and 3 a.m)
(3). A conflict between this inherent sleep preference and social demands can result in a
misalignment in sleep/wake timing, or "social jetlag" (SJL) (6). SJL is calculated as a
difference between mid-sleep on free and work days (6); it reflects the potential
magnitude and direction of time shift for daily activities as well as physiological and
psychological processes (12, 58, 91). Evening chronotypes tend to accumulate a sleep
debt during the week for which they try to compensate during the weekend by extending
their sleep period. For example, if a person with evening chronotype on work days sleeps
between midnight and 6 a.m., his mid-sleep is at 3 a.m. If, on free days, their sleep is
extended from midnight until 9 a.m, the mid-sleep is 4:30 a.m, and their SJL is 1 h 30
min. Morning chronotypes, on the contrary, tend to develop sleep debt during the
weekend (6). Circadian misalignment resulting from altered sleep/wake timing may lead
to metabolic alterations: lipid disregulation, decreased insulin sensitivity, impaired
glucose tolerance, altered melatonin and cortisol secretion, and oxidative stress (49, 52,
91). These impacts are commonly observed among shift workers, although some studies
suggest that this relationship may extend to populations not involved in shift work, such
as those with SJL (12, 25, 37, 47, 49, 58, 107, 228). Although clinically significant cut51

points for SJL have not been established, those with ≥2 h of SJL had shorter sleep
duration, higher 5-hour blood cortisol levels, and a higher resting heart rate relative to
those with ≤1 h of SJL (49). In addition, those with >2 h of SJL had higher depression
scores than those with ≤2 h (37). To date, no prospective studies have examined the
persistence of SJL over time.
This study quantitatively assessed sleep and sleep/wake timing among young
adults during two years of follow-up to test the hypothesis that SJL and poor sleep remain
stable over time. Data were obtained from participants in the Energy Balance Study
(EBS), a three-year follow-up study that investigated the effects of energy intake and
expenditure on changes in body weight, body composition and health indices among
healthy young adults ages 21-34 years (182). This age group is at risk for decreasing
metabolic rate and increase in weight and percent of body fat (183, 229) which may lead
to development of chronic disease at a later age. Actigraphy measures repeated at 6month intervals were used to characterize SJL and sleep disturbances at each time point.
To assess the consistency of SJL and sleep disturbances over time, generalized linear
mixed models were used to evaluate the temporal stability of SJL and each sleep
measure, and RMLCA was used to identify subgroups (latent groups) with different sleep
trajectories. Finally, the socio-demographic characteristics of each subgroup was
described, including the extent to which they are influenced by chronotype.
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Methods
Study population
Eligible individuals were 21-35 years of age with no major health conditions or
large changes in body composition during the previous six months, and had a BMI of 2035 kg/m2 (182). Participants were excluded at baseline if they had systolic blood pressure
≥150 mmHg and/or diastolic blood pressure ≥90 mmHg or a blood glucose level >145
mg/dl as diagnostic criteria for hypertension and diabetes, respectively (182). In 2011,
430 participants residing in the Columbia, SC region were enrolled. After comprehensive
baseline assessment, participants were re-examined every 6 months to assess their
demographic and anthropometric characteristics, as well as their sleep/wake patterns via
armband actigraphy, and to ascertain diet using three 24-hour dietary recalls (2 on
random weekdays and one on the weekend). Each participant completed one to five
assessments at six-month intervals over the two-year study period (2011-2013). All
available repeated measures were used to evaluate the temporal characteristics of SJL and
objective sleep measures. Only participants with ≥3 data time points were included in the
RMLCA. The study was approved by the University of South Carolina Institutional
Review Board, and all participants provided informed consent.
Chronotype, social jetlag and other objective sleep measures
All objective sleep measures were derived from the data collected with a
SenseWear® Mini Armband worn by study participants over the triceps muscle of the left
arm (184). A micro-electro-mechanical sensor in the armband recorded limb movements
at a sampling frequency of 32 times per second averaged over 1-minute intervals. All
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participants wore the armband for 7-10 days and kept a log of their activities during
periods of non-wear. These activities were matched with the 2011 Compendium of
Physical Activity (187) to fill gaps in information on energy expenditure and sleep for
non-wear periods (185).
The 1-minute armband data were further summarized using SenseWear
Professional® Research Software (Version 7.0, Body Media® Inc.). Demographic
information (i.e. age, sex, height, weight and smoking status) was used with proprietary
algorithms to calculate objective sleep measures. The armband yields several average
night-time sleep measures: sleep onset and wake-up times, TST, SOL, SE and WASO
(185). The sleep onset time was defined as the first of three minutes asleep that coincided
with ≥10 minutes lying down (185). Wake-up time was defined as the first of 90
consecutive minutes awake following sleep onset (185). TST was defined the sum of all
minutes asleep from initiation of the sleep period until wake-up time (185). SE was
calculated as a proportion of the total sleep time to the length of the night sleep bout.
WASO was calculated as the sum of wake periods of at least two minutes duration
between sleep onset and the final wake time (185). All measures were averaged across
each data collection period using a minimum of 3 weekdays and one weekend day.
Chronotype was defined as the time of mid-sleep on work days corrected for
“make-up sleep” on free days (12). SJL was defined as a difference between unadjusted
midpoints of sleep on a weekend and on a week day (12) and modeled as two continuous
variables: actual and absolute. It was assumed that free days occurred only on weekends,
and rest/activity logs were examined to identify and exclude individuals who did not
conform to this pattern (10). Individuals were also excluded from statistical analyses if
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their armband data had any of the following characteristics: missing bed- or wake-time,
<4 days of data in a given assessment period, missing sleep data on the weekend, extreme
or implausible TST values (<4 hours either on weekdays, free days, or on average, TST
>11 hours on work days or on average), and when mid-sleep on free days occurred in the
afternoon (12). Participants also were excluded if they regularly used sleep promoting
medications (≥3 times per week over the counter or prescription), worked night shifts, or
traveled across meridians during periods of armband use (12, 230).
Covariates
Estimates of total daily physical activity time were obtained from armband data.
Information for the periods of non-wear was supplemented with values for matching
activity from the 2011 Compendium of Physical Activity (184). Total daily hours of
physical activity were defined as any activity of at least 5 metabolic equivalents. Time
napping was obtained from armband data. Dietary information was collected using three
24-hour dietary recalls conducted by phone; two on randomly selected weekdays and one
on a weekend. The Nutrient Data System for Research (version 2012: Nutrition
Coordinating Center, University of Minnesota, Minneapolis, Minnesota) was used to
estimate nutrient and individual food intakes from the dietary recalls. Forty three food
parameters and nutrients were further used to calculate a dietary inflammatory index (eDII) that expresses an inflammatory potential of individual's diet (81). Lower DII scores
are anti-inflammatory while the higher scores are more proinflammatory, and the
maximum theoretical range is −8.87 to 7.98. To account for individual differences in
energy intake, the DII scores were calculated per 1,000 kilocalories (4,184 KJ) (e-DII) as
previously described (185).
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Statistical analyses
All statistical analyses were performed using SAS 9.4 (Cary, NC). Stability of
SJL, absolute SJL, and objective sleep measures (TST, SOL, WASO, SE) over time were
analyzed using generalized linear mixed models for repeated measures for which we
estimated an unstructured covariance matrix. Time was treated as a main exposure
variable (categorical) in crude and adjusted statistical models. The following covariates
were considered: sex (male, female), race (European American [EA], African American
[AA], Other [Hispanic, Asian, Native American or mixed race]), education (high school
graduate/GED some college vs. college ≥ 4 y.), income (<$20,000, 20,000 to <40,000,
40,000 to <60,000, 60,000 to <80,000, ≥80,000), employment (student/other, employed
and self employed), marital status (married, single), having children (yes/no), physical
activity (h), caffeine intake (g/d), e-DII, napping (yes/no), and season (winter
[November-January], spring [February-April], summer [May-July], autumn [AugustOctober]), and current dieting (yes/no). To select potential covariates, bivariate
relationships with objective sleep measures were summarized, and variables with p-value
<0.2 were selected for inclusion in full statistical models. Manual backwards elimination
was used to identify covariates for inclusion in the final model that changed the effect
estimate of the main exposure variable by ±10%. Variables that were statistically
significant (p≤0.05) were included in the final model. Each sleep characteristic was
modeled separately as a continuous variable. These analyses included 390 participants
with valid repeated measures data available (1431 observations). Least squares means of
continuous sleep variables, SJL or chronotype at different time points were compared
using the F-tests in PROC GLIMMIX.
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RMLCA was estimated using PROC TRAJ in SAS to identify latent groups for
each continuous variable (absolute SJL, chronotype, TST, SOL, SE, WASO) (202, 203).
This analysis assumes a mixture model to define the trajectories of unique subgroups
within a population that don't change their group membership over time (204, 205). The
best fitting crude model was selected using Bayesian Information Criterion (205). The
final selection of the number of latent groups was based on the best model fit and
minimum group sizes containing ≥10% of the study population. Analyses for chronotype,
TST and SE were adjusted for race (EA vs. AA or Other) and sex, which were assumed
not to change over time. WASO was adjusted for race only. Absolute SJL and SOL were
not adjusted for race or sex because latent groups were not influenced by these variables.
Since the group trajectories for each measure were linear, potential covariates that change
over time were not examined. Only participants with at least three assessments during the
study period were included into these analyses (n=312). Finally, generalized linear mixed
models was estimated to identify demographic and other characteristics that differed
among the latent classes for absolute SJL and each of the sleep outcomes.

Results
The final analytical dataset consisted of 390 participants (with a total of 1,431
repeated observations). A majority of the participants had at least three (26%), four
(15%), or five (39%) assessments, whereas 11% of participants had one and 10% had two
assessments. The average age at baseline was 28±4 years and the sex distribution was
approximately equal (51% women, Table 4.1). Most participants were EA (68%) and had
at least 4 years of college education (84%). College students comprised 45% of
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participants (19% undergraduate, 81% graduate), and another 55% were employed. A
majority of participants' annual incomes were below $60,000 (71%). Thirty two percent
were married, and 14% had children (Table 4.1).
At baseline, ~50% of participants had ≤1 hour of SJL and another 33% had more
than 1 but less than 2 hours, and 17% had ≥2 hours of SJL. At baseline, SJL was
moderately correlated with chronotype (Spearman r=0.42, p<0.001). Adjusted mean SJL
values at 12 and 24 months exceeded the baseline average by 6 or 12 minutes,
respectively; although the overall linear trend for SJL over two years was not statistically
significant (Table 4.2). A 12 min increase was observed for absolute SJL (p=0.01, data
not shown). TST, SOL, WASO and SE remained stable during the study period, although
a minor difference in mean TST value was observed at 12 months relative to 6 months
(Table 4.2).
Results from the RMLCA indicated that absolute SJL had 2 latent groups with
low (mean±SE, 0.4±0.04 h, 42%) and high (1.4±0.03 h, 58%) values (Figure 1). Minor
changes in absolute SJL were observed over time, although neither trajectory departed
statistically from linearity. If the RMLCA sample was analyzed using the methods that
generated results for Table 4.2, absolute SJL remained stable over the study period
(p=0.1, data not shown). Three latent groups were apparent for chronotype: early
(3.0±0.9 h, 33%), intermediate (4.4±0.9 h, 52%) and late (6.0±1.3 h, 14%). By the end of
the study, a 23 minute phase advance was observed in the late chronotype group,
although no changes were observed in the other two groups. TST had three latent groups
with relatively short (5.6±1.0 h, 21%), intermediate (6.5±1.0, 44%) and long (7.3±1.0 h,
36%) durations, all with temporally stable linear trajectories. SOL was generally low in
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this population (<30 minutes for 98% of observations, median: 13 min); two latent
groups were identified: low (9.7±1.0 min, 73%) and high (18.3±1.0 min, 27%). Two
latent groups were observed for WASO: low (42.1±18.6 min, 77%) and high (90.4±31.0
min, 23%), and for SE: low (74.6±1.0%, 27%) and high SE (85.3±1.0%, 73%). Latent
groups for SJL and each sleep parameter all had linear trajectories that remained stable
over time (Figure 1).
In bivariate analyses, those in high SJL group were employed and had later
chronotypes relative to the low SJL group (Table 4.3). Participants in the short TST
group were younger, male, of AA or Other race, had lower incomes, were married,
consumed less caffeine, and tended to have a more proinflammatory diet (i.e., higher eDII scores) compared with those in the intermediate TST group (Table 4.3). Those in the
long TST group tended to be female, EA, have higher incomes and no children relative to
those with an intermediate TST (Table 4.3). The SOL latent groups differed only by
employment status; students had a higher SOL relative to those who were employed
(Table 4.4). The two WASO groups differed only by race (Table 4.4); a higher proportion
of those with elevated WASO values were of AA or Other race. Among those with low
SE, a higher proportion was male, AA or Other race, had lower incomes and consumed
less caffeine (Table 4.4). Overall, participants with poor sleep (e.g., high SOL, high
WASO, short TST, or low SE) tended to have an evening chronotype.

Discussion
To our knowledge, this is the first study that used actigraphy measures to
prospectively describe SJL along with chronotype, TST, SOL, WASO and SE in a non59

clinical population of young adults. The prevalence of SJL in the current study was
comparable with previous studies of SJL among adults (≥1 hour: 63-69%, ≥2 h: 26-33%)
(12, 49). A majority of participants (58%) was in a latent class with SJL exceeding one
hour (mean: 1.4 h at baseline) that increased slightly during the two-year study period
(mean: 1.5 h at 24 months). SJL tended to remain stable during the study, whereas by the
end of the two-year follow-up, chronotype shifted to an average of 23 minutes earlier.
Because the heritability of chronotype may be up to 50% (9), one might not expect such a
change within a two year span. However, the phase advance observed in the present study
is consistent with results from a large cross-sectional study, which suggested that
chronotype gradually becomes earlier after age 20 (88). In a series of large internet
surveys, SJL gradually decreased over time between the ages 20 and 35 years and was
higher among males than females (6, 12). However, it is unclear whether this represents
age-related changes, some form of adaptation, or random variation, or unaccounted
cohort effects. Temporal patterns of SJL within individuals have not been reported
previously. In the present study, SJL was more common among those with an evening
chronotype, and was higher among those who were employed compared to students or
those not in the work force. These observations agree with the concept that SJL results
from misalignment between an individual's social and biological timing (6). These
findings also are consistent with previous observations that young adults with later
chronotypes had greater SJL (12, 49, 58). SJL may be associated with increased risk of
depression, metabolic syndrome, obesity and cardiovascular disease (12, 37, 49, 58, 92,
107, 228) (12, 37, 49, 58, 92, 107, 228). Thus, understanding the temporal dynamics of
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SJL and factors that contribute to increased SJL risk is important for development of
disease preventive strategies targeting SJL and the disruption of sleep/wake timing.
To our knowledge, this also is the first longitudinal study to examine objective
sleep measures among young adults (21-35 years old) over an extended time period. Poor
sleep, defined as a low TST or SE, and elevated SOL or WASO, persisted during the
two-year follow-up; 21% of study participants had a short TST (mean: 5.6 h), 32% had
elevated WASO (mean: 90 min), 27% had low SE (mean: 75%), and in 27% of
participants, SOL was elevated (mean: 19 min). The mean values for sleep parameters in
the above groups are consistent with cut-off values for TST, SOL, WASO, and SE that
have been used to define disrupted sleep or insomnia in prior studies: <6 h for TST (231234), ≥12 min for SOL (185, 191), ≥50 min for WASO (185), and <78% (233) or <85%
for SE (185). RMLCA was used in this study to define temporal trajectories of
chronotype and SJL using objective measures of sleep and sleep/wake timing (34, 38,
235). The characteristics of poor sleep in the latent groups identified by RMLCA were
generally consistent with categorizations used previously. For example, mean TST values
among latent groups coincided with categories used to define short (≤6 h), intermediate
(6-7 h), or long sleep (≥7 h) (61, 65, 231). The mean values for low and high SOL among
latent groups in this study (11 and 19 min, respectively) allowed for segregation based on
some previously suggested cut-off points (12 min and 15 min) (191, 236), but were lower
than the 30-minute value that has been used previously to characterize insomnia (115,
237). Mean values in the low- and high- latent groups for WASO (means: 42 and 91 min,
respectively) were both above the previously described cut-point of 30 min for insomnia
(115, 237). Finally, the mean values among latent groups of SE (low mean: 75%; high
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mean: 85%) identifies two groups that are above and below the previously used cut-point
for insomnia of 80% (115, 237); however, they were both below the suggested cut-point
from another study (92%) (191).
Some limitations in this study are noteworthy. Information on work schedules was
not available for all participants, thus it was assumed that participants worked on
weekdays and had free days on weekends. Approximately 45% of participants were
students (81% at a graduate level), who typically attend classes and work part-time
during the day. A few students may have had evening jobs, although it is unlikely they
regularly worked night shifts due to the potential interference with their education.
Another potential limitation is that no information was available on alarm clock use on
free days. To minimize these potential impacts, participants with extreme or implausible
TST values were excluded from the analyses, consistent with prior studies (12, 37). In
addition, the generalizability of these results is limited to healthy adults ages 21-35, half
of whom were college students and had a relatively low income < $40,000.
A major strength of this study is the use of objective measurements to
characterize SJL, chronotype, and sleep, which avoids issues related to self-report of
sleep or sleep/wake timing. Armband actigraphy is a valid, non-invasive method for
obtaining ‘real-life’ sleep/wake measurements that are compatible with the "gold
standard" method of polysomnography (184). Armband data were collected minute-byminute over several days, and information for non-wear periods was obtained using logs
completed by participants. Thus, measurement error was expected to be lower than self
report information. Participants did not have any major acute or chronic health conditions
that could potentially affect objective sleep measures, and those who regularly used
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sleep-promoting medications were excluded. Therefore, confounding by somatic
conditions or sleep disorders was unlikely to bias the results.
Studies using multiple cross-sectional analyses suggest that sleep tends to
deteriorate with age (total sleep time and SE decrease, WASO and SOL increase) (88,
238). In middle-aged and elderly adults, prospective studies using repeated actigraphic
measures of sleep reported that sleep characteristics remained generally stable within a 1
to 2.5-year time frame, although insomnia subtypes changed over time (66, 67, 225, 226).
Prospective studies among college students that used questionnaires to assess sleep
produced conflicting results with respect to the temporal stability of sleep duration and
the number of nocturnal awakenings during a one-semester time frame (126, 127).
Among undergraduate college students, sleep duration decreased and the number of
awakenings increased as the semester progressed (126). However, in another study, sleep
duration and quality increased during a 15-week spring semester (127). In a cohort of 591
young adults surveyed for over 20 years, 35% of those with incident one-month insomnia
still had it at the next interview and the cumulative prevalence of one-month insomnia
was 20% (220). Forty percent of those with incident insomnia subsequently developed
chronic insomnia, and 17-50% of those with insomnia had a subsequent major depressive
episode (220). Results of these studies suggest that sleep disruption tends to be persistent,
although some inconsistencies have been observed in both younger and older age groups.
Whether the observations in the present study correspond to more chronic sleep
disruption that extends beyond two years remains to be determined. Given the persistent
character of insomnia and other sleep disorders in terms of their reported association with
chronic diseases such as depression (37, 220, 239), obesity (213, 240, 241), diabetes (62,
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120), hypertension (63, 118, 242), CVD (65) and cancer (28), the identification of
susceptible subgroups of young adults with persistent sleep disruption may provide a
health benefit to those individuals in terms of chronic disease prevention. The
demographic characteristics identified in this study that may contribute to persistent sleep
disruption include: male sex, being a student, non-White race, low income, and evening
chronotype.
In summary, this study adds to knowledge concerning the temporal patterns of
SJL, chronotype, and actigraphic sleep among healthy young adults. Absolute SJL, TST
and objectively measured insomnia symptoms remained stable over a two-year span. The
findings may contribute to the development of prevention strategies targeting sleep
hygiene among young adults to prevent the chronic disease development.
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Table 4.1 Demographic characteristics of the Energy Balance Study sample at baseline after
basic exclusions
Variable

All Participants
(n=390)
27.6±3.8

Women
(n=198)
27.7±3.7

Age (yrs)
Race, n (%)
European American
264 (68)
131 (66)
African American
47 (12)
31 (16)
Hispanic/Latino
11 (3)
7 (3)
Asian
42 (11)
15 (8)
Native American
12 (3)
8 (4)
Other
14 (3)
6 (3)
Education, n (%)
HS Graduate/GED
62 (16)
18 (9)
Some College
College (4+ years)
328 (84)
180 (91)
Income ($), n (%)
< 20,000
65 (17)
34 (17)
20,000 to < 40,000
137 (35)
76 (39)
40,000 to < 60,000
74 (19)
37 (19)
60,000 to < 80,000
50 (13)
23 (12)
≥ 80,000
62 (16)
26 (13)
Employment, n (%)
Employed and self
214 (55)
113 (57)
employed
Student/Other1
176 (45)
85 (43)
Marital status, n (%)
Married2
178 (46)
90 (45)
Single3
212 (54)
108 (55)
Children, age
<18 years, n (%)
0
336 (86)
173 (88)
1
29 (7)
13 (7)
≥2
24 (7)
11 (5)
1
Out of work (<1 year), homemaker, unable to work (n=4, 1 %).
2
Includes members of unmarried couples (n=55, 14 %).
3
Includes divorced and separated (n=7, 1.7 %).
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Men
(n=192)
27.4±3.9
133 (70)
16 (8)
4 (2)
27 (14)
4 (2)
8 (4)
44 (23)
148 (77)
31 (16)
61 (32)
37 (19)
27 (14)
36 (19)
101 (53)
91 (47)
88 (46)
104 (54)
163 (85)
16 (8)
13 (7)

Table 4.2 Stability of Objective Sleep Measures Over Time (n=390, 1,431 observations)

Sleep measure

Baseline
(n=390)
Mean±SE

Follow-up Time (Months)
6
12
18
(n=341)
(n=317)
(n=206)
Mean±SE Mean±SE Mean±SE

24
(n=177)
Mean±SE

F-test,
p-value

66

Social Jet Lag (h)
Crude
1.2±0.04
1.1±0.04
1.1±0.05
1.2±0.06
1.2±0.06
0.78
Adjusted1
0.9±0.05
0.9±0.05
1.0±0.05*
1.0±0.1
1.1±0.1*
0.09
Chronotype (h)
Crude
4.4±0.1
4.2±0.1*
4.1±0.1*
4.1±0.1*
4.0±0.1*
<0.01
Adjusted2
4.4±0.1
4.2±0.1*
4.1±0.1*
4.0±0.1*
4.0±0.1*
<0.01
Total Sleep Time (h)
Crude
6.6±0.04
6.6±0.04* 6.5±0.04*
6.6±0.05
6.6±0.05
0.10
Adjusted3
6.4±0.10
6.5±0.10*
6.3±0.10*
6.4±0.1
6.4±0.10
0.40
Sleep Onset Latency (min)
Crude
12.9±0.3
13.0±0.3
12.9±0.3
13.8±0.4
12.6±0.4
0.15
4
Adjusted
12.9±0.3
12.8±0.4
12.7±0.4
13.6±0.4
12.4±0.5
0.16
Wake After Sleep Onset (min)
Crude
53.8±1.5
54.2±1.6
53.3±1.6
54.0±1.8
51.9±1.9
0.75
5
Adjusted
61.3±2.2
61.6±2.3
60.7±2.3
61.4±2.4
59.3±2.5
0.77
Sleep Efficiency (%)
Crude
82.3±0.3
82.4±0.3
82.4±0.4
82.1±0.4
82.6±0.4
0.76
Adjusted6
81.2±0.4
81.3±0.4
80.3±0.4
82.0±0.5
81.5±0.5
0.77
Abbreviations: 95%CI - 95% Confidence Interval. Participants with any valid time points (1-5) were included.
1
Adjusted for time, chronotype, race, employment status, and current dieting. 2 Adjusted for age and sex.
3
Adjusted for time, chronotype, gender, race, having children (yes/no), caffeine intake (g/d), napping (yes/no),
physical activity (MET-hours, continuous) and season. 4Adjusted for time, season, income, caffeine, nap, physical
activity (MET-hours, continuous). 5 Adjusted for race. 6 Adjusted for race, sex, income, energy-adjusted Dietary
Inflammatory Index (continuous), and physical activity (MET-hours, continuous).* p<0.05. For absolute SJL time
points 12 and 24 months differed from baseline. For Chronotype, every time point was different from the baseline.
For TST, time points 6 and 12 m were different from each other.

Table 4.3 Characteristics of Latent Groups within Social Jetlag, Chronotype, and Total Sleep Time
(n=312; 1,297 observations)

Variable

Sex
Male
Female
Race
European American
African American
Other1
Employment
Student/Other2
Employed
Income ($)
< 20,000
20,000 to < 40,000
40,000 to < 60,000
60,000 to < 80,000
≥ 80,000
Marital status
Married3
Single4
Children
Yes
No

Social Jet Lag (h)
Low
High
Mean±SE Mean±SE
0.8±0.6
1.4±0.8
%
%

p

Total Sleep Time (min)
Short
Intermed.
Long
Mean±SE Mean±SE Mean±SE
5.6±0.04
6.5±0.02
7.3±0.03
%
%
%

p

55
45

48
52

0.20

71*
29*

54
46

35*
65*

<0.01

64
12
24

68
10
22

0.50

27*
30*
43*

71
9
20

82
2
16

<0.01

52
48

41
59

0.05

50
50

46
54

43
57

0.70

19
36
19
13
13

16
38
19
14
13

0.80

24*
43*
23*
4*
6*

16
38
21
16
9

16*
30*
16*
16*
22*

0.02

46
54

46
54

0.96

70*
30*

50
50

50
50

0.02

17
11
13
18
8*
0.10
0.10
83
89
87
82
92*
Mean±SE Mean±SE
Mean±SE Mean±SE Mean±SE
Chronotype (h)
3.8±0.1
4.3±0.05 0.01
4.6±0.1*
4.1±0.1
3.9±0.05
<0.01
Age (yrs)
27.8±0.2
27.6±0.1 0.30
27.0±0.2*
28.0±0.2
27.7±0.2
<0.01
Physical activity (h)
2.2±0.1
2.2±0.1 1.00
2.3±0.2
2.3±1.0
2.0±0.1*
0.04
Caffeine (g/d)
109.0±8.6 117.4±6.8 0.50 79.3±11.7* 120.2±7.9 126.5±8.8 <0.01
e-DII
0.4±0.2
0.6±0.1 0.40
1.1±0.2*
0.4±0.1
0.3±0.2
0.01
Abbreviations: SE - standard error, e-DII - energy-adjusted Dietary Inflammatory Index; p - p-value F-test.
1
Hispanic/Latino, Asian, Native American, mixed race. 2 Out of work (<1 year), homemaker, unable to
work. 3 Includes members of unmarried couples. 4 Includes divorced and separated. *p<0.05, reference
group Intermediate Chronotype.

67

Table 4.4 Characteristics of latent groups within sleep variables (n=312, N=1,297 observations)

Variable
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Sex
Male
Female
Race
European American
African American
Other1
Employment
Student/other2
Employed
Income ($)
< 20,000
20,000 to < 40,000
40,000 to < 60,000
60,000 to < 80,000
≥ 80,000
Marital status
Married3
Single4
Children
Yes
No
Chronotype (h)
Age

Sleep Onset Latency
Low
High
Mean±SE

Mean±SE

10.8±0.2
%

19.2±0.3
%

49
51

54
46

68
11
21

p

Wake After Sleep Onset
Low
High
Mean±SE

Mean±SE

42.1±0.9
%

90.7±1.7
%

0.50

51
49

50
50

61
11
28

0.50

75
7
18

41
59

58
42

0.01

8
33
22
14
13

17
46
12
13
12

47
53

p

Sleep Efficiency
High
Low

p

Mean±SE

Mean±SE

85.4±0.1
%

74.8±0.3
%

0.99

47
53

60
40

36
24
40

<0.01

76
7
17

40
20
40

<0.01

43
57

54
46

0.10

43
57

51
49

0.20

0.20

16
34
19
16
15

26
45
19
5
5

16
32
21
14
16

20
48
15
11
6

0.04

42
58

0.30

47
53

41
59

0.40

48
52

40
60

0.20

12
88

18
82

0.30

14
86

12
88

0.60

14
86

11
89

0.40

Mean±SE

Mean±SE

Mean±SE

Mean±SE

Mean±SE

Mean±SE

4.0±0.04
27.6±0.1

4.3±0.01
27.8±0.2

4.0±0.04
27.7±3.6

4.4±0.1
27.6±4.2

4.0±0.1
27.9±0.1

4.4±0.1
27.1±0.2

<0.01
0.40

0.10

0.01
0.30

0.04

<0.01
<0.01

Physical activity (h)
2.3±0.1
2.0±0.1
0.10
2.2±0.1
2.1±0.1
0.60
2.2±0.1
2.1±0.1
Caffeine (g/d)
114.3±3.8
114.2±6.4
0.80
119.9±6.1
94.6±11.2
0.05
124.2±6.2
87.2±10.1
e-DII
0.5±0.1
0.5±0.2
0.90
0.4±0.1
0.6±0.2
0.40
0.4±0.1
0.6±0.2
Abbreviations: WASO stands for Wake After Sleep Onset, SE - Standard Error, e-DII - energy-adjusted Dietary Inflammatory Index,
p - p-value F-test.
1
3

Hispaic/Latino, Asian, Native American, mixed race. 2 Out of work (<1 year), homemaker, unable to work.
Includes members of unmarried couples. 4 Includes divorced and separated

0.60
0.01
0.40
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Figure 4.1. Latent group trajectories for Social Jetlag, Chronotype and Objective Sleep
Measures at five time points (baseline, 6 m, 12 m, 18 m, and 24 m) obtained with RMLCA
analyses (n=312, 1,297 obs.). Only participants with ≥3 time points were included.
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CHAPTER 5
Relationships between Social Jetlag, Chronotype and Objective Sleep
Characteristics with Anthropometric Indices of Obesity and High Blood Pressure1

1

McMahon, D.M., Burch, J., Wirth, M.D., Youngstedt, S.D., Hardin, J.W., Hurley, T.G.,
Blair, S.N., Hand, G.A., Shook, R.P., Drenowatz, C., Hebert, J.R. To be submitted to
Chronobiology International.
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ABSTRACT
Background: Chronotype, social jetlag and poor sleep have been associated with
increased risk of chronic diseases such as obesity, metabolic syndrome, cardiovascular
disease and cancer. Yet, the relationships between these factors have not been extensively
investigated in prospective studies.
Methods: Social jetlag [SJL] and objective sleep measures (total sleep time [TST], sleep
onset latency [SOL], wake after sleep onset [WASO] and sleep efficiency [SE]) were
derived from physical activity personal (armband) monitoring data among 390 healthy
men and women 21-35 years of age. Participants wore the armband for 7-10 days at 6month intervals (1,431 repeated measurements). Generalized linear mixed models with
repeated measures (PROC GLIMMIX) were used to analyze relationships between
chronotype, absolute SJL, TST, SOL, WASO, SE and anthropometric measures: body
mass index [BMI], percent body fat [%BF], waist-to-hip ratio [WHR], waist-to-height
ratio [WHtR], systolic blood pressure [SBP] and diastolic blood pressure [DBP]. The
relationships between sleep disruption or SJL and indicators of obesity and high blood
pressure were evaluated for potential effect modification by chronotype.
Results: Sleep latency ≥12 min was associated with 1.4 times increased odds of high
WHtR (odds ratio [OR]=1.4; 95% confidence interval [95%CI]: 1.03-1.84). The odds of
high WHtR decreased 0.97 times (95%CI:0.95-0.99) per 1% increase in SE. SJL was
correlated with eveningness (Spearman ρ=0.49, p<0.001), and evening chronotypes had
shorter TST, lower SE and higher WASO compared to those with intermediate
chronotypes. Chronotype and absolute SJL were not associated with anthropometric
measures. However, chronotype modified relationships between objective sleep measures
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and anthropometric measures. Morning chronotypes with short TST (<6 h), low SE
(<85%) and large WASO (≥60 min) had increased odds of high %BF, WHR and WHtR,
whereas morning chronotypes with longer sleep latencies (≥12 min) had increased odds
of high SBP. Among evening chronotypes, shorter sleep (<6 hours) was associated with
increased odds of high SBP.
Conclusions: Chronotype and sleep disturbances may work in combination to increase
an individual's risk of obesity or elevated blood pressure.

Introduction
In 2013-2014, almost 38% of adults in the United States were obese (243).
Obesity is associated with many serious complications such as metabolic syndrome, type
2 diabetes mellitus, arterial hypertension, cardiovascular disease, and cancer (244), some
of which develop already in a childhood (183). One modifiable risk factor for obesity is
sleep (213, 245). Poor sleep has been associated with has been associated with increased
risk of major chronic diseases such as cardiovascular disease and hypertension (65, 118),
obesity (213), diabetes (120, 214), and cancer (28, 47).
Sleep timing is related to individual circadian preference and is more efficient
when it occurs during preferred times (246). Most physiological and behavioral processes
in humans follow ~24-hour internally generated cycles that are synchronized (or
entrained) by environmental stimuli, the most important of which is light (1, 2). Due to
inherent differences in sleep/wake timing, people tend to be categorized into morning
("larks"), neutral, or evening ("owls") chronotypes (3, 4). For example, people with a
morning chronotype go to bed between 10 p.m. and midnight, on average, while evening
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chronotypes retire between 1 and 3 a.m on their free days. Individuals with evening
chronotypes tend to accumulate sleep debt during the week, for which they try to
compensate with a longer sleep during the weekend. Morning chronotypes, on the
contrary, tend to develop sleep debt during the weekend (6). Modern life in industrialized
countries imposes on individuals multiple work-related and social demands that can come
into conflict with the individual's chronotype. This discrepancy (misalignment) between
biological preference and social clock is called "social jetlag" (SJL) (6). SJL is calculated
as the difference between mid-sleep time on free and work days (6). For instance, if on a
work day, a person sleeps from 1 a.m. to 7 a.m. and on free days from 1 a.m. to 9 a.m.,
his SJL is 1 hour. In experimental studies, circadian misalignment has been implicated in
disruption of important physiological processes (92). Social jetlag starts in teenage years
and continues throughout working years until retirement and, thus, may affect millions of
people in industrialized countries (12). In some reports, SJL has been associated with
increased anthropometric indices of obesity, metabolic syndrome, markers of systemic
inflammation and mood disorders (12, 37, 49, 58); however, its relationships with other
factors, such as sleep disruption and chronotype, that also predispose to chronic disease
have not been thoroughly examined.
In several studies, individuals with evening chronotype were more likely to be
overweight or obese than those with morning or intermediate chronotypes (33, 53-55);
however, not all studies confirmed this association (12, 57). In one study, morning
chronotype was associated with increased risk of weight gain (12). Chronotype
moderately correlates with social jetlag, especially on work days, and people with
evening chronotypes tend to have more social jetlag (6, 12, 37, 49, 58, 236). Chronotype,
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in combination with social schedule, can elicit an increase in social jetlag (6, 12). Thus, it
is reasonable to hypothesize that social jetlag may mediate the relationship between
chronotype and obesity. A study that tested this hypothesis produced conflicting results
(56), and most other studies inferred that chronotype, SJL and sleep duration confound
each other's associations with anthropometric indexes of obesity and metabolic syndrome
(12, 58).
Sleep duration is generally independent from chronotype (88); however, circadian
misalignment, a discrepancy between preferred and actual sleep/wake times, is associated
with sleep loss (6, 88). Shortened, fragmented or inefficient sleep is associated with
increased risk of weight gain and obesity in young adults (54, 213, 232, 234, 236, 240,
247). Poor sleep is prevalent in young adults and tends to be persistent (116, 234, 236,
240, 248, 249). For instance, a recent study showed that in 53% of young adults 19-23
years old, sleep problems persisted over 3 years (249). Our previous research also
demonstrated that SJL and poor sleep (low TST, high SOL, high WASO and low SE)
derived from armband actigraphy in young adults 21-35 years old remained stable within
two year period (submitted). Findings that sleep disruption is associated with chronic
diseases warrants further investigation into the interplay between sleep quality, quantity
and timing.
The objective of this study was to prospectively examine relationships between
SJL, objective sleep measures (TST, SOL, WASO and SE) and anthropometric measures
of obesity and high blood pressure (BMI, %BF, WHR, WHtR, SBP, and DBP) among
young adults 21-35 years old using a serial cross-sectional study design. This age group
is at risk for developing metabolic disturbances that predispose to increased risk for
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chronic disease later in life (183, 229). During the last decade, prevalence of obesity in
this age group in the United States remained high (30%) (183), a known risk factor for
morbidity and premature mortality (250). Adults in this age range also may experience
SJL and have persistent poor sleep (116, 234, 236, 240, 248, 249). We hypothesized that
young adults with SJL or poor sleep were more likely to be obese, have elevated blood
pressure, mood disturbances or elevated stress relative to those without SJL and good
sleep, and that such impacts may be modified by chronotype.

Methods
Study population
Eligible individuals were 21-35 years of age, with BMI of 20-35 kg/m2 , and no
major health conditions or large changes in body composition during previous six months
(182). In 2011, 430 healthy men and women 21-35 years of age residing in the Columbia,
SC region were enrolled. Those who met diagnostic criteria for hypertension and
diabetes: systolic blood pressure ≥150 mmHg and/or diastolic blood pressure ≥90 mmHg
or a blood glucose level >145 mg/dl, were excluded (182). In 2011, 430 participants
residing in the Columbia, SC region were enrolled. After comprehensive baseline
assessment, participants were re-examined every 6 months for: socio-demographic and
anthropometric characteristics, sleep/wake patterns via armband actigraphy, and diet.
During the two-year study period, each participant completed one to five assessments at
six-month intervals. The study was approved by the Institutional Review Board at the
University of South Carolina, and all study participants provided informed consent.
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Chronotype, Social Jetlag and Sleep measures
Objective sleep measures were derived from the data collected using a
SenseWear® Mini Armband which participants wore over the triceps muscle of the left
arm (184). A micro-electro-mechanical sensor in the armband detects and measures limb
movements at a frequency of 32 times per second and data are averaged at 1 minute
intervals. The armband data by minute were analyzed using SenseWear Professional®
Research Software (Version 7.0, Body Media® Inc.). Demographic information (i.e. age,
sex, height, weight and smoking status) was used to customize proprietary algorithms for
calculations of objective sleep measures. The participants wore the armband for 7-10
days and kept a log of their activities during periods of non-wear. These activities were
matched with the 2011 Compendium of Physical Activity (187) to fill gaps in
information on energy expenditure and sleep for non-wear periods (185).
The armband data yields several night-time sleep measures: sleep onset and wakeup times, TST, SOL, WASO and SE (185). The sleep onset time was determined by the
first out of three minutes asleep that coincided with ≥ 10 minutes lying down (185).
Morning wake-up time was defined by the first out of 90 consecutive minutes awake
(185). TST is the sum of all minutes asleep from initiation of the sleep period until wakeup (185). Sleep efficiency was calculated as a proportion of the total sleep time to the
length of the night sleep bout. WASO was calculated as the sum of wake periods of at
least two minutes long between sleep onset and the final wake time (185). All sleep
measures were averaged for each semiannual data collection period for a minimum of 3
weekdays and one weekend day.
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Chronotype was measured as the time of mid-sleep on free days corrected for
“make-up sleep” on free days (12). Information on work schedule was not collected in
this study; it was assumed that free days occurred only on weekends. The sleep logs were
examined to find and exclude individuals whose schedules deviated from this pattern
(10). Social jetlag (SJL) was calculated as a difference between midpoints of sleep on a
weekend and on a week day (unadjusted) (12). The absolute value of SJL was used for all
analyses and, referred to as SJL throughout this paper.
Individuals were excluded from statistical analyses if their armband data had the
following deficiencies: missing bed time or wake time, <4 days of actigraphy in any
given assessment period, missing sleep data on the weekend, extreme or implausible TST
values (<4 hours either on week days, free days, or on average, TST >11 hours on work
days or on average), and when mid-sleep on free days occurred in the afternoon (12). In
addition, participants were excluded from all analyses if they regularly used (≥3 times per
week) sleep promoting medications (over the counter or prescription), worked night
shifts, or traveled across meridians during periods of armband wear (12, 230).

Anthropometric Outcomes
Height and weight were measured using traditional stadiometer and electronic
scales with a precision of 0.1 cm and 0.1 kg, respectively (182). The average of three
measurements was used to establish BMI (weight (kg)/height (m2). Waist and hip
circumferences were measured with a calibrated, spring-loaded tape measure. The waist
circumference was measured at mid-point between costal margin and iliac crest on the
axillary line on both sides of the trunk and 2 cm above the umbilicus (182). Hip
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circumference was measured at the level of the greater trochanter, at the widest point.
The average of three measurements rounded to 0.1 cm was recorded. Body composition
was measured using dual x-ray absorptiometry full body Lunar fan-beam scanner (GE
Healthcare model 8743, Waukesha, WI).

Covariates
Total daily physical activity time was obtained from armband data. Information
for the periods of non-wear was supplemented with values for matching activity from the
2011 Compendium of Physical Activity (184). Total daily hours of physical activity were
defined as any activity of at least 5 metabolic equivalents. Dietary information was
collected using three 24-hour dietary recalls conducted by phone; two on randomly
selected week days and one on a weekend. To estimate energy, nutrient and individual
food intakes from these recalls was used the Nutrient Data System for Research (version
2012: Nutrition Coordinating Center, University of Minnesota, Minneapolis, Minnesota).
Forty three food parameters and nutrients were further used to calculate a dietary
inflammatory index (DII) that expresses an inflammatory potential of individual's diet
(81). Lower DII scores are anti-inflammatory while the higher scores are more
proinflammatory, and the maximum theoretical range is −8.87 to 7.98. To account for
individual differences in energy intake, the DII scores were calculated per 1,000
kilocalories (4184 KJ) (e-DII) (185).

Statistical Analyses
All statistical analyses were performed using SAS 9.4® (Cary, NC). Continuous
actigraphy variables were categorized using previously established cut-points: TST (<6,
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6-<7, ≥7 h) (61, 65), SOL (≥12 vs. <12 min) (191), WASO (≥60 vs. <60 min) (119, 188),
and SE (<85 vs. ≥85%) (119, 185). Relationships between SJL, chronotype, objective
sleep measures (TST, SOL, WASO, SE) and anthropometric measures were analyzed
using generalized linear mixed models for repeated measures for which we estimated an
unstructured covariance matrix. Odds ratios (OR) and 95% confidence intervals (95%CI)
were used to evaluate the relationship between disrupted sleep, individual chronotype, or
SJL and measures of obesity, body composition, or blood pressure. BMI was categorized
into 2 groups: underweight/normal weight (<25) and overweight/obesity (≥25 B kg/m2).
Sex-specific cut-off points were used to categorize BF% and WHR. Obesity was defined
as BF% ≥25% in men and ≥30% in women (98). WHR was dichotomized: <0.95 vs.
≥0.95 in men and <0.80 vs. ≥0.80 in women (200). Waist-to-height ratio was
dichotomized as <0.5 vs. ≥0.5 (103). Potential covariates included: age, sex (male,
female), race (European American [EA], African American [AA], Other [Hispanic,
Asian, Native American and mixed race]), education (high school graduate/GED some
college vs. college ≥ 4 y.), income (<$20,000, 20,000 to <40,000, 40,000 to <60,000,
60,000 to <80,000, ≥80,000), employment (student/other vs. employed/self-employed),
marital status (married, single), having children (yes/no), physical activity (MET-hours),
caffeine intake (g/d), e-DII (≤-1.18, -1.19-≤0.72, 0.73-≤2.10, >2.10), napping (yes/no),
and season (winter [November-January], spring [February-April], summer [May-July],
autumn [August-October]). The assessment time (one to five at 6-month intervals) was
treated as a categorical variable and included in crude and adjusted statistical models. To
select potential covariates, bivariate relationships between each sleep measure and the
anthropometric outcomes were summarized, and variables with p-value <0.2 were

80

selected for inclusion in multivariable statistical models. Manual backwards elimination
was used to identify covariates that changed an estimate of the main exposure by ±10%.
The final model included only confounders detected with 10% rule, or if they were
statistically significant (p≤0.05). Only observations with complete data were included.
Repeated Measures Latent Class Analysis (RMLCA) was estimated using PROC
TRAJ in SAS® to identify latent groups for chronotype (morning, intermediate, and
evening) over time (202, 203). This analysis assumes a mixture model to define the
trajectories of unique subgroups within a population that don't change their group
membership over time (204, 205). Assignment to a latent group was based on the highest
posterior probability. The best fitting model was selected using Bayesian Information
Criterion (BIC) (205) and a priori minimum group sizes ≥10% of the study population.
RMLCA were adjusted for race (EA vs. AA/Other) and sex, which were assumed not to
change over time. Because the group trajectories for all three latent chronotype groups
were linear, other potential covariates that change over time were not used to adjust
group trajectories. Participants with complete armband data for any available time point
were included in these analyses (n=390, 1,431 observations). Generalized linear mixed
models were estimated to compare means of SJL, chronotype and each continuous sleep
measure between chronotypes using the F-tests in PROC GLIMMIX. The intermediate
chronotype was a referent group.
Because chronotype may have several possible roles in how it influences
anthropometric outcomes, it was analyzed in several different ways. Chronotype was
used as either a continuous or a categorical (RMLCA) independent variable; in the latter
analysis, the intermediate chronotype was used as the referent. When examining
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relationships between SJL or sleep measures and the anthropometric outcomes,
chronotype (continuous) was considered as a potential confounder along with other
covariates. The potential role of chronotype as effect modifier was tested using two
approaches. In the first approach, an interaction term between chronotype and a main
independent variable was added to the multivariable statistical model and assessed using
the Wald test. The continuous or categorical version of chronotype that was used for the
interaction term was chosen to match the form of the other independent variable. The
second approach used stratification of the relationship between absolute SJL, sleep
measures and anthropometric outcomes by latent chronotype group.

Results
The final analytical dataset consisted of 390 participants (with a total of 1,431
repeated observations). A majority of the participants had at least three (79%), four
(15%) or five (39%) repeated assessments, whereas 10% of participants had two, and
11% had only one assessment. The average age at baseline was 28±4 years, and the sex
distribution was approximately equal (51% women) (Table 4.1). Most participants were
EA (68%) and had at least 4 years of college (84%). Fifty five percent of participants
were employed, and 45% were college students (19% undergraduate, 81% graduate). A
majority of participants (71%) had an annual income below $60,000. Thirty two percent
of participants were currently married, and 14% had children (Table 4.1). With regard to
anthropometric characteristics, 45% of participants were overweight (BMI 25-24.9
kg/m2, 31%) or obese (BMI≥30, 14%). Among males, 37% had %BF ≥25% and 3% had
high WHR (≥0.95). Among females, 71% had %BF ≥30% and 15% had high WHR
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(≥0.80). Twenty two percent of participants of both sexes had high WHtR (≥0.5).
Systolic blood pressure was elevated (≥120 mmHg) among 59% of participants,
including those who met a criterion for hypertension (≥140 mmHg, 11%). Only 23% had
elevated DBP (≥80 mmHg), including those with hypertension (≥90 mmHg, 4%).
Chronotype was not associated with any of the anthropometric measures when
analyzed as a continuous variable (Table 5.1). The RMLCA identified three latent
chronotype groups: morning (mean±SE: 3.0±0.04 h, 32.5% of participants), intermediate
(4.4±0.03 h, 53%) and evening (6.1±0.1 h, 14.5%). Chronotype defined by latent group
membership was not associated with any anthropometric measures (Table 5.1). At
baseline, chronotype was moderately correlated with SJL (Spearman ρ=0.42, p<0.001).
Compared to participants with an intermediate chronotype (1.2±0.03 h), morning types
had significantly less SJL (0.9±0.04, p<0.001), whereas those with evening chronotypes
had significantly more of SJL (1.5±0.1 h, p<0.001) (Table 5.2). The evening types also
had significantly shorter TST, lower SE and larger WASO relative to intermediate types
(Table 5.2).
Approximately 50% of participants at baseline had more than one hour of SJL (>1
hour and <2 hours: 33%; ≥2 hours: 17%). SJL was not associated with any of the
anthropometric measures either before or after stratification by chronotype group (Table
5.3).
Among the sleep measures, SOL, SE, and TST were associated with
anthropometric measures. Sleep latency ≥12 min (Ref. <12 min) was associated with an
increased odds of elevated WHtR (OR: 1.4, 95%CI: 1.03-1.84, Table 5.4). The odds of
high WHtR decreased 0.97 times (95%CI:0.95-0.99) per 1% increase in SE (Table 5.4).
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The odds of elevated SBP decreased 0.8 times (95%CI: 0.66-0.97) per 1 hour increase in
TST; although it was not confirmed in adjusted analysis (Table 5.4). Chronotype
continuous) was not included into the final models due to the negative tests for
confounding (10% rule).
Stratification by latent chronotype group indicated that morning types who also
had short TST (<6 h), elevated WASO (≥60 min) or low SE (<85%) were more likely to
have increased %BF, WHR and WHtR (Table 5.5). Participants with sleep latency ≥12
min who also had a morning chronotype were 1.9 times more likely to have elevated SBP
(95%CI: 1.15-3.16, pinteraction=0.02, Table 5.5). Among the late chronotypes, the odds of
high SBP were 2.6 times greater among those who also had short TST (<6 h, 95%CI:
1.08-6.40, pinteraction=0.74, Table 5.5). Elevated WASO (≥60 min) was associated with an
increased odds of high DBP only among those with an intermediate chronotype (OR: 1.7,
95%CI: 1.05-2.71, pinteraction=0.10, Table 5.5). Results obtained when the data were
analyzed using sleep measures as continuous variables were generally consistent with
those obtained using categorical sleep variables. For example, among morning types, the
odds of an elevated WHR or WHtR decreased with each 1% increase in SE (OR=0.91;
95%CI: 0.85-0.98, pinteraction=0.004 and OR=0.95; 95%CI: 0.91-0.98, pinteraction=0.14,
Table 3). Measures of chronotype, SJL or sleep were not associated with BMI.

Discussion
To the author’s knowledge, this is the first study to use repeated actigraphy
measures to examine relationships between chronotype, SJL, and objective sleep
measures to characterize longitudinal associations with anthropometric indices of obesity
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or hypertension. This study revealed that among healthy adults ages 20-35 years,
disrupted sleep was associated with %BF and WHtR, whereas SJL and chronotype had
no direct association with the anthropometric outcomes. These observations are
consistent with previous studies that found an association between sleep disruption and
risk of weight gain or obesity in young adults (213, 231, 232, 234, 236, 240, 241). In the
current study, measures of body composition and abdominal adiposity (%BF, WHR,
WHtR) tended to be most strongly associated with sleep measures, whereas the results for
BMI and sleep measures did not indicate an association. In this study, those with larger
SOL were predisposed to elevated WHtR, whereas increases in SE and sleep duration
were protective. Short TST was associated with increased WHR, although only among
morning types. Others have reported that short sleep duration was associated with
increased waist circumference among women, although the participants' chronotypes
were not evaluated (233, 241). Disrupted sleep in the current study, defined as short TST,
high SOL, high WASO, or low SE, was not associated with BMI, whereas relationships
with indices of %BF, WHR and WHtR were observed. The reasons for these
discrepancies are uncertain but may be due to minor differences in the accuracy of the
indicator. For example, BMI likely underestimates obesity among those with BMI <30
kg/m2 (251), or overestimates among college athletes (252) relative to percent body fat.
Most studies found that evening types were more likely to be obese compared to morning
types (33, 51, 53-55). However, one large cross-sectional study reported that morning
circadian preference was associated with increased BMI (12). In the present study, the
lack of association between chronotype and BMI is in agreement with findings reported
in another study (58).
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Although chronotype had no direct associations with outcomes in the present
study, relationships between sleep disturbances and the anthropometric measures were
modified by chronotype. Morning types with disrupted sleep, characterized as either short
TST, elevated WASO, or low SE, had increased odds of increased %BF, WHR and
WHtR. This finding is relatively novel since most previous studies investigated the
effects of chronotype or sleep on obesity independently (33, 51, 53-55, 213, 231-234,
236, 240, 241). Some studies adjusted for the effects of chronotype and sleep duration
while examining the relationship between absolute SJL and BMI, percent fat mass, waist
circumference, and obesity (12, 58). Increase in SJL or morningness, or decrease in sleep
duration were independently associated with increased odds of being overweight or obese
while adjusted for the other two variables (12). In the same study, among people with
normal weight, chronotype and sleep duration were associated with BMI while SJL was
not. Among overweight or obese people, SJL and decrease in sleep duration were
associated with increase in BMI, and chronotype was not a significant predictor. In
another study, SJL was associated with increase in BMI, fat mass, waist circumference
and obesity while chronotype and sleep duration in the same statistical model were not
associated with those measures (58). It is not clear why measures of disrupted sleep were
associated with increases in anthropometric indexes of obesity predominantly among
morning types. It suggests that a morning circadian preference increases vulnerability to
the detrimental effects of sleep disturbance, and that the effect is linked to physiological
processes controlling fat deposition. In another study, morning chronotypes had higher
baseline and postprandial total cholesterol, lower low density lipoprotein and a higher
adiponectin compared to intermediate or evening chronotypes (46). In the same study,
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participants with morning chronotypes had higher baseline glucose levels and the greatest
increases in postprandial blood glucose levels compared to other chronotypes (46).
Others have observed that morning chronotypes had a higher cortisol awakening response
relative to evening types (48, 253) and a stronger homeostatic response to sleep
fragmentation than evening types (254). Morningness has been associated with decreased
quality of sleep, problems maintaining sleep, and early awakenings relative to
eveningness (45), which may be related to the tendency towards shift work intolerance
that has been observed in this group (13, 14).
In the current study, an interaction between sleep disturbances and chronotype
also was observed in relation to arterial hypertension. Among evening chronotypes, those
with TST <6 hours were 2.6 times more likely to have elevated SBP compared to those
who slept 6 to less than 7 hours. In another study that examined blood pressure, there was
no statistically significant interaction between sleep duration and chronotype; although
TST ≤ 6 hours and evening chronotype were independently associated with increased risk
of arterial hypertension (46). Evening chronotypes tend to have shorter sleep duration on
work days relative to other chronotypes (88, 255). Poor sleep also is common among
evening types (255, 256), consistent with results from the present study (236). Short or
fragmented sleep may initiate a neuroendocrine stress response, leading to increased
activity of the sympathoadrenal and hypothalamo-pituitary axis, which in turn can
increase heart rate, blood pressure, increase evening cortisol, impair glucose metabolism,
and lead to abdominal adiposity (257-259).
Absolute SJL was not associated with any of the anthropometric indices of
obesity in this study. In prior cross-sectional studies, SJL was associated with increased
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BMI, fat mass, and waist circumference (12, 58, 228). In one study, SJL predicted
increases in BMI only among those who were already overweight or obese (12). It is not
clear why results from the present study were inconsistent with those of others. This
present study used quantitative actigraphic armband data to characterize SJL, whereas
others typically used self-report information to ascertain sleep/wake timing. The current
study had fewer individuals with elevated absolute SJL relative to other studies (>1h 51%
vs. 63-69%, ≥2h 16% vs. 26-30%, respectively) where the majority of participants were
Caucasians in the age range 15-65 y. (12, 49, 58). Other studies asserted that SJL,
chronotype, and sleep duration confound relationships of one another with obesity
measures (12, 58, 228). It is plausible that the relationships between these variables are
more complex. For instance, it has been proposed that SJL may mediate rather than
confound the relationship between chronotype and anthropometric measures (49, 56). If
this is the case, adjustment for mediator may introduce bias. Since in this study, neither
chronotype nor SJL were associated with anthropometric outcomes, it was not possible to
conduct a mediation analyses to test this hypothesis. Participants of this study did not
have any major acute or chronic health conditions that could potentially affect sleep, and
those who regularly used sleep promoting medications, both over the counter and
prescription, were excluded. Therefore, confounding by somatic conditions or sleep
disorders was unlikely to bias the results. Alternatively, the study population was
relatively young and healthy, thus they may have been more resilient to the potential
effects of sleep disturbances or changes in sleep/wake timing on measures of total and
central obesity and blood pressure.
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This study also has a few noteworthy limitations. Since work schedules were not
available for all participants, it was assumed that they only worked on weekdays and
were free on weekends. Approximately 45% of study participants were graduate students
who typically attend classes and work part-time during the day. Regular night work may
be less likely in this population since it would potentially interfere with coursework. In
any case, to diminish the possible influence of shift work on the study results, participants
with extreme or implausible sleep schedules (TST values <4 hours either on week days,
free days, or on average, or mid-sleep time in the afternoon) were excluded (12, 37, 230,
255). Also, no information was available on alarm clock use on free days. Finally, the
generalizability of these results is limited to healthy adults ages 21-35, half of whom
were college students with relatively low incomes (<$40,000).
The main strength of this study was the use of actigraphic measurements to define
SJL, chronotype, and sleep disruption, which avoids issues inherent to self-report data.
Armband actigraphy is a convenient, non-invasive and relatively inexpensive method for
quantifying sleep that is comparable with the "gold standard" method of
polysomnography (184). The armbands provided minute-by-minute measurements over
several days, and information for non-wear periods was obtained by inspecting the data
and using logs completed by participants. Other study strengths included: the use of a
repeated measures design to increase statistical power, the use of gender-specific cutpoints for obesity measures, which decreases potential misclassification of outcomes (98,
99, 103, 200), and a statistical modeling strategy that accounted for possible temporal
changes and correlated data within individuals. The RMLCA was used to categorize
participants into latent chronotype groups based on individual trajectories over time. This
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‘data-driven’ approach provided clear contrasts among those with different chronotypes
and served as a robust method for defining chronotype groups (3, 37, 235). The
prevalence of early (32.5%), intermediate (53%) and late (14.5%) chronotype groups
using RMLCA in this study was comparable with chronotype distributions in the same
age range (23-35 y.) from larger cross-sectional surveys (255, 256).
In summary, this study found that disrupted sleep (SOL, SE, TST) had a modest
association with central obesity and high SBP, whereas crude associations between short
TST and SBP were not statistically significant after adjustment for confounding. A
somewhat unexpected finding was that neither chronotype nor SJL were independently
associated with the anthropometric outcomes measured. However, chronotype tended to
modify the relationship between disrupted sleep and the anthropometric measures. Those
with poor sleep and a morning chronotype were more likely to have excess body fat and
central obesity. Evening chronotypes who slept <6 hours had increased odds of elevated
SBP. The complex relationships between sleep, chronotype, SJL and anthropometric
indices of obesity and hypertension deserve careful examination in the future studies.

90

Table 5.1 Relationships between Chronotype and Anthropometric Characteristics
Anthropometric

Model

characteristic

Chronotype (continuous)
OR (95% CI)

p-value

Body Mass Index (kg/m2) Crude
Adjusted1

0.91 (0.79-1.06)
0.86 (0.76-1.03)

Percent body fat

Crude
Adjusted1

Waist-to-hip ratio

Chronotype group (ref. Intermediate)
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Late
OR (95% CI)
0.95 (0.39-2.28)
1.22 (0.50-2.97)3

p-value

0.24
0.12

Early
OR (95% CI)
1.56 (0.81-2.98)
1.49 (0.80-2.78)3

1.01 (0.86-1.17)
1.11 (0.94-1.31)

0.94
0.22

0.67 (0.35-1.30)
0.77 (0.40-1.50)4

0.45 (0.18-1.12)
1.41 (0.54-3.69)4

0.17
0.48

Crude
Adjusted2

0.83 (0.68-1.01)
0.86 (0.69-1.07)

0.07
0.17

1.24 (0.64-2.44)
1.18 (0.56-2.48)5

0.58 (0.20-1.66)
1.66 (0.46-6.06)5

0.38
0.71

Waist-to-height ratio

Crude
Adjusted2

0.96 (0.82-1.13)
0.98 (0.83-1.17)

0.64
0.86

1.30 (0.67-2.52)
1.38 (0.70-2.73)2

0.70 (0.30-1.98)
1.36 (0.50-3.72)2

0.55
0.60

Systolic BP (mmHg)

Crude
Adjusted1

1.00 (0.90-1.11)
0.96 (0.87-1.07)

0.90
0.47

1.21 (0.81-1.81)
1.16 (0.79-1.72)1

1.81 (1.04-3.13)
1.10 (0.63-1.90)1

0.10
0.74

0.36
0.45

Crude
1.07 (0.96-1.20)
0.22
0.95 (0.62-1.44)1 1.83 (1.06-3.16)1
0.06
Adjusted1
1.04 (0.93-1.16)
0.49
0.89 (0.59-1.34)
1.19 (0.68-2.07)
0.61
Abbreviations: BP - blood pressure, OR - odds ratio, 95%CI - 95% confidence interval.
Cutoff points for anthropometric characteristics: Body Mass Index (≥25 vs. <25 kg/m2), percent body fat (males ≥25 vs. <25 %,
females ≥30 vs. <30 %), waist-to-hip ratio (males ≥0.95 vs. <0.95, females ≥0.8 vs. <0.8), waist-to-height ratio (≥0.5 vs. <0.5),
systolic BP (≥120 vs. <120 mmHg), diastolic BP (≥ 80 vs.<80 mmHg).
1
Adjusted for time, sex, physical activity (MET-hours, continuous). 2 Adjusted for time, age, sex, physical activity (MET-hours,
continuous). 3 Adjusted for time, sex, physical activity (MET-hours, continuous) and income.4 Adjusted for time, sex, race and
physical activity (MET-hours, continuous).5 Adjusted for time, age, sex, race, physical activity (MET-hours, continuous) and
employment status.
Diastolic BP (mmHg)

Table 5.2 Objective Sleep Characteristics by Latent Chronotype Group (n=390, 1,431
observations)
Variable

Early
32.5%
Mean±SE
3.0±0.04*
6.4±0.1
6.3±0.1

Intermediate
53%
Mean±SE
4.4±0.03
6.4±0.1
6.3±0.1

Late
14.5%
Mean±SE
6.1±0.1*
6.1±0.1*
6.1±0.1*

F-test,
p-value

Chronotype (h)
<0.01
1
Total Sleep Time (h)
0.01
Total Sleep Time on
0.06
work days (h)2
Sleep latency (min)2
11.1±0.04
11.6±0.03
10.6±0.1
0.35
3
Sleep efficiency (%)
81.4±0.5
81.3±0.5
78.8±0.8*
0.01
WASO (min)4
58.5±2.4
58.4±2.0
66.1±3.4*
0.11
Absolute SJL (h)5
0.9±0.04*
1.2±0.03
1.5±0.1*
<0.01
Abbreviations: WASO - Wake After Sleep Onset, SJL - Social Jetlag, 95%CI - 95% confidence
interval. Partial F-test in GLIMMIX with repeated measures and unstructured covariance matrix.
*p<0.05 (Reference group - Intermediate chronotype).
1
Adjusted for time, sex, race, having children, employment status, physical activity and caffeine
intake. 2 Adjusted for time, sex, race, employment status, physical activity (MET-hours,
continuous). 3 Adjusted for time, sex, race, employment status and caffeine intake. 4 Adjusted for
time, sex and having children.
5
Adjusted for time and employment status.
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Table 5.3 Relationships between Absolute Social Jetlag (continuous) and
Anthropometric Characteristics
Anthropometric

Chronotype

characteristic

group

OR (95% CI)

F-test

p
interaction

Body Mass Index1 (kg/m2)

All
0.93 (0.73-1.16)
0.71
Early
0.96 (0.61-1.51)
0.85
0.82
Intermediate 0.98 (0.72-1.34)
0.90
Late
0.98 (0.57-1.69)
0.95
Percent body fat1
All
0.90 (0.70-1.15)
0.41
Early
0.82 (0.51-1.32)
0.41
0.91
Intermediate 0.96 (0.67-1.36)
0.81
Late
0.77 (0.40-1.50)
0.44
Waist-to-hip ratio1
All
0.81 (0.59-1.12)
0.20
Early
0.78 (0.43-1.42)
0.41
0.29
Intermediate 0.73 (0.46-1.14)
0.17
Late
1.58 (0.64-3.90)
0.31
2
Waist-to-height ratio
All
1.00 (0.77-1.29)
0.98
Early
1.04 (0.57-1.91)
0.90
0.89
Intermediate 1.01 (0.71-1.43)
0.96
Late
0.99 (0.53-1.85)
0.98
1
Systolic BP (mmHg)
All
1.12 (0.95-1.31)
0.19
Early
0.92 (0.67-1.25)
0.59
0.37
Intermediate 1.31 (1.03-1.67)
0.03
Late
0.99 (0.69-1.42)
0.95
Diastolic BP1 (mmHg)
All
1.02 (0.86-1.21)
0.83
Early
0.89 (0.62-1.27)
0.51
0.38
Intermediate 1.04 (0.81-1.33)
0.78
Late
1.08 (0.74-1.57)
0.69
Abbreviations: BP - blood pressure, OR - odds ratio, 95%CI - 95% confidence interval
Cutoff points for anthropometric characteristics: Body Mass Index (≥25 vs. <25 kg/m2),
percent body fat (males ≥25 vs. <25 %, females ≥30 vs. <30 %), waist-to-hip ratio (males
≥0.95 vs. <0.95, females ≥0.8 vs. <0.8), waist-to-height ratio (≥0.5 vs. <0.5), systolic BP
(≥120 vs. <120 mmHg), diastolic BP (≥80 vs. <80 mmHg).
1
Adjusted for time, sex and physical activity (MET-hours, continuous). 2 Adjusted for time,
age, sex and physical activity (MET-hours, continuous).
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Table 5.4. Relationships between Sleep Measures and Anthropometric Measures
Anthropometric
characteristic

Body Mass Index (kg/m2)

Model

Crude
Adjusted
Crude
Adjusted

Percent body fat

Crude
Adjusted

94

Crude
Adjusted
Waist-to-hip ratio

Crude
Adjusted
Crude
Adjusted

Waist-to-height ratio

Crude
Adjusted
Crude
Adjusted

Systolic BP (mmHg)

Crude
Adjusted

Total Sleep Time (ref. 6-<7 h)

Sleep Efficiency

Sleep Latency

Wake After
Sleep Onset

OR (95%CI)
OR (95%CI)
<6 h
≥7 h
1.28 (0.77-2.10)
1.01 (0.65-1.57)
1.30 (0.77-2.19)1 0.87 (0.55-1.37)1
continuous
0.88 (0.67-1.14)
0.81 (0.62-1.06)1
<6 h
≥7 h
0.88 (0.53-1.49)
1.02 (0.64-1.64)
1.00 (0.57-1.77)3 0.75 (0.45-1.24)3
continuous
1.07 (0.81-1.41)
0.83 (0.62-1.12)3
<6 h
≥7 h
1.16 (0.62-2.18)
1.17 (0.66-2.09)
1.34 (0.68-2.63)5 0.98 (0.53-1.80)5
continuous
1.09 (0.79-1.52)
0.93 (0.63-1.31)5
<6 h
≥7 h
1.16 (0.62-2.18)
1.17 (0.66-2.09)
1.58 (0.88-2.83)5 0.76 (0.45-1.30)5
continuous
0.83 (0.62-1.12)
0.76 (0.56-1.04)5
<6 h
≥7 h
1.36 (0.95-1.96)
0.90 (0.64-1.25)
1.26 (0.87-1.81)3 0.95 (0.68-1.33)3

OR (95%CI)
<85 vs. ≥85%
1.03 (0.68-1.54)
0.96 (0.64-1.48)1
continuous
1.00 (0.97-1.03)
1.01 (0.97-1.04)1
<85 vs. ≥85%
0.98 (0.65-1.48)
0.95 (0.60-1.51)4
continuous
0.97 (0.94-1.00)
1.02 (0.93-1.01)4
<85 vs. ≥85%
1.22 (0.72-2.08)
1.20 (0.68-2.12)5
continuous
0.98 (0.94-1.02)
0.98 (0.94-1.03)5
<85 vs. ≥85%
1.14 (0.89-1.47)
1.16 (0.86-1.55)5
continuous
0.98 (0.06-1.00)
0.97 (0.95-0.99)5
<85 vs. ≥85%
0.98 (0.96-1.01)
1.15 (0.85-1.55)3

OR (95%CI)
≥12 vs. <12 min
1.06 (0.72-1.55)
0.99 (0.67-1.45)2
continuous
1.01 (0.98-1.05)
1.00 (0.97-1.04)2
≥12 vs. <12 min
1.41 (0.94-2.10)
1.41 (0.91-2.16)3
continuous
1.04 (1.00-1.07)
1.03 (1.00-1.07)3
≥12 vs. <12 min
1.25 (0.76-2.06)
1.23 (0.73-2.08)5
continuous
1.00 (0.96-1.04)
0.97 (0.94-1.03)5
≥12 vs. <12 min
1.29 (1.01-1.65)
1.37 (1.03-1.84)6
continuous
1.03 (1.01-1.04)
1.02 (1.00-1.04)6
≥12 vs. <12 min
1.13 (0.85-1.50)
1.05 (0.79-1.40)3

OR (95%CI)
≥60 vs. <60 min
1.04 (0.67-1.60)
0.97 (0.63-1.51)1
continuous
1.00 (0.99-1.01)
1.00 (0.99-1.01)1
≥60 vs. <60 min
1.35 (0.86-2.14)
1.31 (0.80-2.14)3
continuous
1.01 (1.00-1.02)
1.01 (1.00-1.02)3
≥60 vs. <60 min
1.31 (0.76-2.24)
1.23 (0.69-2.18)3
continuous
1.00 (1.00-1.01)
1.00 (0.99-1.01)3
≥60 vs. <60 min
1.15 (0.71-1.87)
1.30 (0.96-1.75)5
continuous
1.00 (1.00-1.01)
1.00 (1.00-1.01)5
≥60 vs. <60 min
1.32 (0.96-1.82)
1.31 (0.95-1.79)5

continuous
continuous
continuous
continuous
0.80 (0.66-0.97)
0.98 (0.95-1.00)
1.02 (0.99-1.04)
1.00 (1.00-1.01)
0.86 (0.71-1.04)3
0.98 (0.96-1.01)3 1.01 (0.98-1.03)3 1.00 (1.00-1.01)5
<6 h
≥7 h
<85 vs. ≥85%
≥12 vs. <12 min
≥60 vs. <60 min
Diastolic BP (mmHg)
Crude
1.26 (0.85-1.86)
1.18 (0.83-1.70)
1.12 (0.81-1.54)
1.16 (0.86-1.58)
1.24 (0.89-1.73)
Adjusted
1.18 (0.80-1.75)3 1.28 (0.89-1.84)3 1.04 (0.75-1.43)3 1.08 (0.79-1.46)3 1.23 (0.88-1.73)5
continuous
continuous
continuous
continuous
Crude
0.86 (0.70-1.05)
0.97 (0.95-1.00)
1.02 (0.99-1.04)
1.00 (1.00-1.01)
Adjusted
0.92 (0.75-1.12)3
0.98 (0.96-1.01)3 1.01 (0.98-1.03)3 1.00 (1.00-1.01)5
Abbreviations: WASO - Wake After Sleep Onset, BP - blood pressure, OR - odds ratio, 95%CI - 95% confidence interval.
Cutoff points for anthropometric characteristics: Body Mass Index (≥25 vs. <25 kg/m2), percent body fat (males ≥25 vs. <25 %, females ≥30
vs. <30 %), waist-to-hip ratio (males ≥0.95 vs. <0.95, females ≥0.8 vs. <0.8), waist-to-height ratio (≥0.5 vs. <0.5), systolic BP (≥120 vs.
<120 mmHg), diastolic BP (≥80 vs. <80 mmHg).
1
Adjusted for time, sex, income and physical activity. 2 Adjusted for time, sex, employment status and physical activity. 3Adjusted for time,
sex, physical activity. 4 Adjusted for time, sex, physical activity and sleep latency.5 Adjusted for time, age, sex and physical activity.
6
Adjusted for time, age, sex, race and physical activity.
Crude
Adjusted

95

Table 5.5 Relationships between Sleep Measures and Anthropometrics stratified by Latent Chronotype Group
Anthropometric
characteristic

Chronotype
group

Body Mass Index
(kg/m2)

Early
Intermediate
Late
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Total Sleep Time (ref. 6-<7 h)
<6 h
≥7 h
OR (95%CI)
OR (95%CI)
0.98 (0.34-2.82)1
1.01 (0.42-2.44)2
1.63 (0.79-3.37)1
0.81 (0.45-1.47)1
1
1.31 (0.33-5.27)
1.77 (0.28-11.18)1
0.99
0.88 (0.30-2.57)2
0.69 (0.27-1.73)2
2
0.83 (0.37-1.86)
0.79 (0.40-1.56)2
2
1.23 (0.28-5.48)
0.59 (0.09-3.79)2
0.92
3.91 (1.19-12.84)5
1.39 (0.42-4.54)5
5
0.66 (0.25-1.78)
0.82 (0.37-1.80)5
2.01 (0.19-21.28)5 1.36 (0.16-11.59)5
0.15
1.59 (0.47-5.39)5
0.60 (0.21-1.72)5
1.76 (0.79-3.84)5
0.85 (0.42-1.70)5
5
1.05 (0.22-5.09)
1.65 (0.26-10.31)5
0.74
0.70 (0.36-1.38)5
0.65 (0.37-1.16)5
5
1.45 (0.85-2.46)
1.09 (0.68-1.75)5
5
2.63 (1.08-6.40)
2.31 (0.74-7.27)5
0.74
0.83 (0.38-1.81)2
1.51 (0.79-2.90)2

Sleep Efficiency
<85% vs. ≥85%
OR (95%CI)
1.12 (0.52-2.43)2
0.99 (0.57-1.71)2
0.60 (0.17-2.11)2
0.69
1.22 (0.53-2.84)4
0.80 (0.43-1.50)4
0.68 (0.14-3.30)4
0.64
3.38 (1.07-10.69)5
0.95 (0.46-1.95)5
0.20 (0.03-1.30)5
0.03
1.89 (1.10-3.25)5
0.87 (0.58-1.30)5
0.95 (0.39-2.32)5
0.05
1.05 (0.63-1.75)2
1.24 (0.81-1.89)2
0.96 (0.41-2.22)2
0.95
0.67 (0.38-1.20)2

Sleep Latency
≥12 vs. <12 min
OR (95%CI)
1.17 (0.55-2.51)3
1.04 (0.62-1.75)3
1.26 (0.43-3.74)3
0.97
1.73 (0.81-3.72)2
1.33 (0.73-2.41)2
1.18 (0.29-4.82)2
0.84
2.13 (0.83-5.47)2
1.06 (0.54-2.10)2
0.19 (0.03-1.20)2
0.27
1.63 (0.94-2.84)6
1.44 (0.96-2.18)6
0.87 (0.37-2.09)6
0.13
1.90 (1.15-3.16)2
0.90 (0.59-1.35)2
0.63 (0.29-1.35)2
0.02
0.83 (0.47-1.45)2

WASO
≥60 vs. <60 min
OR (95%CI)
0.88 (0.37-2.10)1
1.26 (0.69-2.29)1
1.38 (0.39-4.86)1
0.32
3.43 (1.35-8.72)2
0.71 (0.37-1.38)2
1.38 (0.30-6.26)2
0.03
3.72 (1.38-10.07)2
0.67 (0.30-1.51)2
0.42 (0.06-2.90)2
0.01
2.21 (1.27-3.84)5
0.81 (0.53-1.24)5
1.28 (0.55-2.94)5
0.007
1.19 (0.67-2.09)5
1.38 (0.87-2.18)5
1.21 (0.55-2.66)5
0.93
0.94 (0.50-1.78)5

pinteraction
Percent body fat
Early
Intermediate
Late
pinteraction
Waist-to-hip
Early
ratio
Intermediate
Late
pinteraction
Waist-to-height
Early
ratio
Intermediate
Late
pinteraction
Systolic BP,
Early
mmHg
Intermediate
Late
pinteraction
Diastolic BP,
Early
mmHg
Intermediate 1.44 (0.81-2.54)2
1.46 (0.88-2.40)2
1.41 (0.90-2.22)2
1.40 (0.90-2.16)2
1.68 (1.05-2.71)5
Late
1.15 (0.49-2.72)2
0.63 (0.20-2.01)2
0.72 (0.30-1.74)2
0.79 (0.36-1.73)2
0.73 (0.32-1.64)5
pinteraction
0.50
0.13
0.33
0.10
Abbreviations: WASO - Wake After Sleep Onset, BP - blood pressure, OR - odds ratio, 95%CI - 95% confidence interval.
pinteraction: p-value for the interaction term between a sleep variable and chronotype group in adjusted statistical model.

Cutoff points for anthropometric characteristics: Body Mass Index (≥25 vs. <25 kg/m2), percent body fat (males ≥25 vs. <25%, females
≥30 vs. <30%), waist-to-hip ratio (males ≥0.95 vs. <0.95, females ≥0.8 vs. <0.8), waist-to-height ratio (≥0.5 vs. <0.5), systolic BP (≥120
vs. <120 mmHg), diastolic BP (≥ 80 vs.<80 mmHg).
1
Adjusted for time, sex, income and physical activity. 2Adjusted for time, sex, physical activity (MET-hours, continuous). 3 Adjusted for
time, sex, employment status and physical activity (MET-hours, continuous). 4Adjusted for time, sex, physical activity (MET-hours,
continuous) and sleep latency. 5Adjusted for time, age, sex and physical activity (MET-hours, continuous).6 Adjusted for time, age, sex,
race and physical activity (MET-hours, continuous).
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CHAPTER 6
Diet-Related Inflammatory Index and Prostate Cancer Risk in the
California Men's Health Study1

1

McMahon, D.M., Burch, J., Hebert, J.R., et al. To be submitted to Urology.
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ABSTRACT
Background: Recent studies suggest that the inflammatory potential of individuals' diets
may be associated with increased risk of Prostate Cancer (PrCA) whose incidence and
mortality vary by race and socioeconomic status.
Methods: The association between energy-density Dietary Inflammatory Index (e-DII)
and incident PrCA was examined among participants in the California Men's Health
Study (CMHS) (N=40,161). The men were 45-69 years old at recruitment (2002-2003)
and followed for a mean of 9.7 years (SD=3.83).
The e-DII was calculated based on a food frequency questionnaire (FFQ) at
baseline and categorized into quartiles with lower e-DII scores representing a more antiinflammatory diet. Incident PrCA cases were ascertained via linkage with the Kaiser
Permanente Northern California Cancer Registry (KPNCCR) and were categorized into
three groups: high-risk intermediate-high and low-risk. Accelerated failure time models
with log-logistic distribution were fit to model time-to-development of incident PrCA.
Cox proportional hazards models were used to calculate hazard ratios (HR) and 95%
confidence intervals (95% CI) of high- and intermediate- risk PrCA. In all analyses, the
lowest quartile of e-DII was used as the referent group.
Results: Time-to-development of incident total PrCA did not differ by quartile of e-DII,
although there was a suggestion of a shorter time to diagnosis for those in the highest
quartile (Acceleration Factor (AF)Q4 vs.Q1=1.07; 95%CI:0.95-1.20). In race-stratified
analyses, the time to diagnosis was significantly shortened only among Whites (AFQ4
vs.Q1=1.16;

95%CI:1.01-1.34). The HR for high-risk PrCA was increased by 36% in the

third quartile of the e-DII (HRQ3 vs.Q1=1.36; 95%CI:1.04-1.76); however, there was no
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increased risk in the fourth quartile (HRQ4 vs.Q1=0.99; 95%CI:0.74-1.32, ptrend=0.74). The
HR for high-risk PrCA was the highest among Blacks (HRQ3 vs.Q1=3.77; 95%CI:1.2911.06) and Other (HRcontinuous=1.23; 95%CI:1.03-1.48). The e-DII was not associated
with intermediate- and low-risk PrCA incidence.
Conclusions: Pro-inflammatory diet may contribute to increased risk of high-risk PrCA,
especially, among Blacks.

Introduction
In the United States, prostate cancer (PrCA) is the most frequently diagnosed and
the second most common cause of cancer death among men (72, 73). During the last 15
years, PrCA mortality rates in the US decreased from 38.6 to 24.6 per 100,000, most
likely due to widespread population-based screening and improved treatment. Despite
this, the absolute number of incident PrCA is expected to increase substantially as babyboomers age (260). In the United States, PrCA incidence and mortality rates vary by race
and are the highest among African Americans who tend to be diagnosed at a younger age
and with more aggressive disease than their European-American counterparts (72, 73).
According to age-adjusted estimates for 2013, PrCA incidence in African Americans is
70% and mortality is 2.4 times higher than in European Americans (72, 73). PrCA
incidence and mortality in Hispanics/Latino and Asian-Americans are lower than in
African- and European Americans (73).
Few modifiable PrCA risk factors have been established. Thus, further
characterization of PrCA risk factors is important for bolstering prevention efforts.
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Currently, only increasing age, African ancestry, and a family history of the PrCA
are considered well-established PrCA risk factors (73). Evidence suggests that persistent
inflammation within the prostate due to infections, physical trauma, urine reflux,
hormonal changes, diabetes, dietary exposures or other environmental factors may play a
role in development of PrCA (136, 138, 261). Increased levels of the inflammatory
markers, C-reactive protein (CRP) in circulation and transcripts of interleukin (IL)-6 gene
in prostate tissue, have been observed among men with PrCA compared to those with
benign prostatic hyperplasia (262, 263). A biological pathway of innate immunity and
inflammation has been associated with risk of advanced PrCA (264). There is evidence
that diet may influence PrCA risk via modulation of inflammation. For instance,
heterocyclic amines, strong dietary mutagens produced in high quantities when cooking
meat, have been associated with prostatic inflammation in animal models, and with
increased PrCA risk in epidemiologic studies (261, 265, 266). In contrast,
phytochemicals contained in cruciferous vegetables (e.g., kale, cauliflower and Brussels
sprouts) exert anti-oxidant, pro-apoptotic, anti-proliferative and anti-metastatic effects in
PrCA cells in vitro, and in animal models (158). It has been reported that some
racial/ethnic minorities are more likely to have diets with low fruit and vegetable
consumption and sedentary lifestyles as compared to non-Hispanic Whites (149-151).
Such lifestyle patterns have been associated with high levels of systemic inflammation, as
expressed by increased levels of CRP (149-151).
Few epidemiologic studies have investigated interrelationships between diet,
inflammation and PrCA (82, 181, 267). Investigators at the University of South
Carolina’s Cancer Prevention and Control Program, created the Dietary Inflammatory
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Index (DII)TM, which calculates the overall inflammatory potential of an individual’s diet
(81). The major advantage of the DII over other dietary indices is that it measures the
inflammatory potential of the individual’s diet based on reported intakes. DII calculation
is based on previous research that entailed reading and scoring nearly 2,000 articles
focusing specifically on inflammation (160). Additionally, individuals’ DII scores are
standardized against a range of actual food intakes observed in 11 different populations
around the world, which facilitates comparability between populations (160). In previous
studies, the DII predicted increased levels of several inflammatory biomarkers including:
CRP (83, 177), IL-6 (169, 170, 179), tumor necrosis factor alpha (170) and homocysteine
(169). A higher, pro-inflammatory DII has been associated with increased risk of
colorectal (174, 180, 268-270), pancreatic (176), and esophageal (165, 271) cancer,
asthma (179), and cardiovascular disease (272).
To date, three investigations examined the relationship between the DII and PrCA
risk; two case-control (82, 181) and one prospective study (267). Men in the highest
(most pro-inflammatory) quartile of the DII had significantly higher risk of PrCA than
those in the first quartile.
The current study characterized the relationship between dietary inflammation
potential and PrCA risk in a prospective cohort study of California men of varying racial
and ethnic composition. The hypotheses of this study was that men with higher (i.e., proinflammatory) DII scores had elevated PrCA risk and a higher risk of more aggressive
PrCA relative to those with anti-inflammatory diets. It was further hypothesized that
these associations would be stronger among African Americans compared with other
races.
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Methods
Study population
The California Men’s Health Study (CMHS) is a large multiethnic cohort of U.S.
male members of Kaiser Permanente (KP), a health insurance provider that covers a large
number of residents of Northern and Southern California. In 2002-2003 the CMHS
recruited 84,170 men 45-69 years of age; 40% of whom were from minority populations,
including Chinese, Hispanic and African Americans. Information about the CMHS
recruitment and data collection procedures are described in detail elsewhere (206).
Briefly, comprehensive information on participants' demographics, health status, family
history of PrCA, medication and supplementation use, and potential PrCA risk factors
such as diet, physical activity and sleep were collected upon enrollment via two mailed
questionnaires (206). All participants provided informed consent and this study was
approved by the Institutional Review boards of Kaiser Permanente Northern California
and the University of Southern Carolina.
The study population was comprised of CMHS participants (Northern California
region only) who had active KP membership for at least one year prior to the enrollment
into the CMHS. Individuals were excluded if they: had any cancer except non-melanoma
skin cancer (n=1,363) at enrollment, were missing information on race/ethnicity (n=346),
or had implausible total daily energy intake (<500 kcal or >6000 kcal, n=958).
Participants who developed PrCA during follow-up but were missing information on
PrCA stage (SEER) also were excluded (n=65).
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PrCA ascertainment
The ascertainment of incident PrCA cases was performed via linkage of CMHS
members to the Kaiser Permanente Northern California Cancer Registry. California state
law requires reporting of all incident cancer cases, and the KPNCCR ascertains and
reports all cases according to the standards established by the National Cancer Institute’s
Surveillance, Epidemiology, and End Result Program (SEER).
In this study, PrCA was categorized into three groups using the updated (2010)
version of the standard PrCA staging system endorsed by the American Joint Committee
on Cancer (AJCC)/International Union Against Cancer (UICC) (212). The high-risk
PrCA group included men with clinically localized high-risk PrCA and advanced, very
high-risk PrCA (≥T3a or PSA>20 ng/ml, or a Gleason score of 8-10, or those who died
from PrCA). The clinically localized, intermediate-risk group consisted of men with T2bT2c, or T1-T2a and PSA10-20, or T1-T2a and a Gleason score of 7. All other men with
PrCA were in the clinically localized, low-risk PrCA group.

Dietary assessment
Information about usual diet during the previous year was obtained at baseline
from a self-administered semi-quantitative food frequency questionnaire (FFQ) using a
version of the Women's Health Initiative FFQ that was modified for use in men and
validated in several studies (207-209). The nutrient contents of an individual's diet were
calculated using the Nutrition Data Systems for Research software (NDSR) (Nutrition
Coordinating Center, University of Minnesota, Minneapolis, MN, USA). The FFQ
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provided information on 27 individual food parameters needed to compute DII scores
(carbohydrate, protein, total fat, alcohol, fiber, cholesterol, saturated fat, MUFA, PUFA,
omega-3, omega-6, trans-fat, Niacin, Thiamin, Riboflavin, B12, B6, Iron, Magnesium,
Zinc, Selenium, vitamin-A, vitamin-C, vitamin-D, vitamin-E, folic acid, and beta
carotene). An individual DII score was computed for each study participant who
completed the FFQ, as described previously (80, 81).
Briefly, for each food parameter in the DII calculation, its "global" mean and
standard deviation were obtained using a "world" database compiled from 11 countries
around the world (USA, Mexico, England, Denmark, India, Australia, New Zealand,
Bahrain, Scotland, South Korea and Japan) (82). For each participant, this global mean
was then subtracted from the amount of consumed nutrient and divided by the global
standard deviation, yielding a food-specific z-score. The z-scores were then converted
into percentile scores in order to minimize the effect of the right skew characteristic of
dietary data. In order to center the values around zero, these values were doubled and 1
was subtracted from each value. These centered percentile scores were multiplied by an
inflammatory effect score previously derived for each food parameter based on an
extensive literature review and evidence ranking of 1,943 relevant peer-reviewed
publications (80, 81). The percentile-scores for all food parameters were summed to
produce a DII score for each study participant which was further adjusted for energy (eDII). Intakes for the 27 food parameters were divided by total estimated energy intake
and multiplied by 1,000. The same technique was applied to the world standard
database. More negative e-DII scores are associated with anti-inflammatory potential,
whereas more positive scores are indicative of more pro-inflammatory potential (160).
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Confounder assessment
Information on all potential confounders was collected at baseline via
questionnaire and medical record review. Physical activity was assessed using questions
adopted from the Coronary Artery Risk Development in Young Adults (CARDIA)
Physical Activity History (210). Analysis of frequency, duration and intensity of
recreational, household and occupational activities yielded a total physical activity
estimate in MET-hours per week (206). The following variables were tested as potential
confounders for inclusion in statistical models: race (White, Black, Asian, Hispanic,
Other), age at baseline (5-year intervals for the overall PrCA risk estimates and 45-55,
56-65, 65-70 years for subgroup analyses), body mass index (BMI) calculated from selfreported weight in kilograms divided by square height in meters (< 25, 25-29.9, ≥30
kg/m2), education (high school equivalent or less; vocational or technical school; some
college, associate or bachelor degree; graduate/professional school), smoking status
(current or former smokers vs. non-smoker), income (<$40,000, $40,000-$59,000, $60$80,000, $80-100,000, >$100,000), regular use of non-steroidal anti inflammatory
medicines (NSAID) (Yes/No), regular multivitamin use (Yes/No), sleep duration (≤6, 7,
≥8 hrs), total physical activity (0-359, 360-1102, 1103-2201, > 2202 MET-min/week),
history of diabetes of any type (Yes/No; recorded diagnosis in the Northern California
KP Diabetes Registry), family history of PrCA in a first-degree relative (Yes/No), and
benign prostatic hyperplasia (BPH).
Statistical analysis
The follow-up time was censored at: diagnosis of incident PrCA, death, gap in KP
membership exceeding 90 days, or the end of the study (December 31, 2014), whichever
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came first. The e-DII was categorized into quartiles based on the distribution in all
participants in the analytic sample (Q1: -6.19 to -3.36; -3.37 to -2.03; -2.04 to -0.55; -0.56
to 4.89). To address potential confounding, variables with >10% missing values were
recoded using indicator variables which had missing values as a separate category. A
manual backwards selection procedure was used to identify covariates for inclusion in
multivariable models. Variables were retained in the final statistical models if their
exclusion resulted in a change in the effect estimate for e-DII by ≥10%. Statistically
significant covariates (α<0.05) also were retained in the final statistical models. The
proportional hazards assumption was tested using graphical (Kaplan-Meyer survival
plots) and regression approaches (cumulative Martingale residuals). Effect modification
was tested using two approaches: Likelihood Ratio Test (LRT) for significance of the
interaction term added to the final model, and stratification of the analysis based on
differing levels of the effect modifier.
In the analysis of the relationships between e-DII and the risk of total PrCA
(PrCA of any stage), the proportional hazards assumption for the e-DII (quartiles) was
not met; thus, the parametric accelerated failure time model was used with a log-logistic
distribution (273). Since the proportional odds assumption was not met, only the
acceleration factor, with 95% confidence interval (CI) was presented.
Cox proportional hazards models were used to assess the relationships between
the e-DII and either high- or intermediate-risk PrCA. The proportional hazards
assumption was violated for sleep and age; therefore, these variables were placed in the
STRATA statement in the PHREG procedure in SAS®. For linear trend tests, the median
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of each e-DII quartile was included in statistical models as a continuous variable with
adjustment for the same confounders that were included in the previous analyses.
Sensitivity analyses were conducted to explore the possible effects of missing
data on the results. Men diagnosed with PrCA during the first 3 years of follow-up were
excluded in order to assess the possibility of reverse causality. In separate analyses, all
participants with missing sleep duration were excluded, and analyses were then repeated
after removal of the sleep duration variable from the statistical models.
All statistical analyses were performed using SAS® 9.4 (Cary, North Carolina)
with significance levels set at α=0.05.

Results
The analytical sample consisted from 40,161 men with mean follow-up of 9.7
years (SD=3.83). From 2002-2003 until December 31, 2014, a total of 2,707 CMHS
participants were diagnosed with incident PrCA.
Participants' characteristics at baseline by quartile of e-DII are presented in Table
6.1. Men in lower quartiles of e-DII were older than those in the upper quartiles. The
proportion of Whites slightly decreased across quartiles of e-DII, while proportion of
Blacks and Hispanics increased. Compared to the first (anti-inflammatory) quartile of eDII, men in the fourth (pro-inflammatory) quartile were more obese, and had lower
educational attainment and income. The proportion of single men increased with quartile
of e-DII, as physical activity and sleep duration decreased. The proportion of smokers
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and regular nonsteroidal anti-inflammatory drug (NSAID) users increased with quartiles
of e-DII, while the proportion of regular multivitamin users decreased.
There was no statistically significant difference in time to development of
incident total PrCA between quartiles of e-DII after adjustment for the effects of age,
race, BPH, family history of PrCA, diabetes, and smoking status (Table 2). Men in the
highest quartile of e-DII developed incident PrCA 7% faster than those in the lowest
quartile (acceleration factor (AF)=1.07; 95%CI: 0.95-1.20). Exclusion of men who were
diagnosed during the first 3 years of follow-up did not alter the relationship between
quartiles of e-DII and incident PrCA (Table 2). In separate sensitivity analyses, exclusion
of those with missing sleep duration, or adjustment for this variable, did not change the
results (Table 6.2). Race modified the relationship between the e-DII and overall PrCA
risk (LRT p=0.0001). In the race-stratified analyses, White men in the fourth quartile of
e-DII had a shorter time (16%) to PrCA diagnosis (AF=1.16;95%CI:1.01-1.34). Among
Black men in the third quartile of e-DII, the time to development of PrCA was longer
(35%) (AR=0.65; 95%CI:0.44-0.96).
Compared to the first quartile of e-DII, HRs for high-risk PrCA increased by 27%
and 36%, respectively, in the second and third quartiles (hazard ratio (HR)Q2vs.Q1=1.27;
95%CI:0.98-1.66, and HRQ3 vs. Q1 =1.36; 95%CI: 1.04-1.76), although there was no
association between the highest and the lowest e-DII quartiles (HR=0.99;95%CI:0.741.32) (Table 6.3). Relationships between e-DII and high-risk PrCA were modified by
race (LRT p=0.0002). In race-stratified analyses, high-risk PrCA among Blacks increased
across e-DII quartiles and was elevated by nearly four-fold among those in the third e-DII
quartile (HRQ3 vs. Q1=3.77; 95%CI:1.29-11.06). Among participants in the multi-
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ethnic/other category, there was a 23% increase in high-risk PrCA per unit e-DII
(HR=1.23;95%:1.03-1.48, Table 6.3). No relationship was observed between e-DII and
the risk of intermediate-risk PrCA (Table 6.3) or low-risk PrCA (data not shown).

Discussion
In this study, the e-DII was not significantly associated with time-to-development
of PrCA when all cases were considered simultaneously. Estimates of the acceleration
factor suggested that it took slightly less time (7%) for men in the most pro-inflammatory
quartile of e-DII to develop incident PrCA compared to those in the lowest e-DII quartile,
but the effect was not statistically significant. Assessment of potential reverse causality
via exclusion of men who developed PrCA during the first 3 years of follow-up did not
change the results. However, a statistically significant 16% decrease in time to total PrCA
development was found among White men with the most pro-inflammatory diets. When
only high-risk PrCA was examined, there was an increased risk with increasing e-DII,
although it was the highest in the third rather than the fourth quartile. Thus, interpretation
of the results is complicated by an apparent lack of monotonic dose-response across
quartiles of e-DII, and by a lack of association when using e-DII as a continuous variable.
Furthermore, the inflammatory potential of the diet was not associated with intermediaterisk PrCA.
To date, three studies have examined the relationship between DII scores and
PrCA. Two case-control studies explored these relationships among Italian and Jamaican
men (82, 181). In the Jamaican study, 229 incident PrCA cases and 250 PrCA-free
controls were recruited from the same urology clinics, two large hospitals and private
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practices between 2006 and 2007 (181). Jamaican men in the highest quartile of the DII
had 2.4 times increased risk of total PrCA relative to men in the "healthiest" first quartile.
Consistent with that result, a prospective study in France found that men in the highest
quartile of the DII had PrCA risks 2.1 times higher than those with anti-inflammatory
diets (267). Of note, the test for PrCA trend across quartiles of DII was not statistically
significant. In a large case-control study conducted in Southern Italy, PrCA risk among
men in the fourth DII quartile was 33% higher than in those in the first quartile (82). In
the current study, no statistically significant differences in time to development of total
PrCA were detected between the lowest and the highest quartiles of e-DII. However, in a
race-stratified analyses, White men in the highest quartile of e-DII had a shorter time (by
16%) to development of PrCA, which is closer to the risk estimates reported for the
above-mentioned case-control study among Italian men (82).
The lack of statistically significant association between e-DII and total PrCA prior
to stratification by race may be attributed to several factors. It is plausible that the
relationship between dietary inflammation potential and PrCA risk may vary by disease
aggressiveness and race. In the Jamaican study, more than 50% of PrCA cases were highgrade (Gleason score ≥7), and all participants were of African descent (181, 274). In this
study, the high-risk PrCA cases represented only 18% of the total number of cases and
Black men represented only 6% of the study population. In race-stratified analyses, the
relationship between e-DII and high-risk PrCA was the strongest and statistically
significant only among Blacks and those in the Multiethnic/Other group (this latter group
included men of races/ethnicities other than Black or White, and could have included
those of mixed race with some African admixture). The risk estimates for e-DII and high111

risk PrCA among Blacks were similar in magnitude to overall PrCA risk in the Jamaican
study (181). Also, DII scores in this study were generally lower than what we see in most
studies examining the role of DII in health.
It is not clear why increased incidence of high-risk PrCA was observed in the
third, but not in the highest (i.e., most pro-inflammatory), quartile of the e-DII. In
ancillary analyses, change of cut-off points (e.g. tertiles or quintiles) did not meaningfully
alter the results. In secondary analyses with DII and total energy intake as a separate
variable, the risk of high-risk PrCA did not differ between second, third and forth
quartiles of DII (HR=1.11;95%CI:0.76-1.63). After exclusion of cases diagnosed during
first 3 years of follow up, the risk of high-risk PrCA was the highest in fourth quartile but
was not statistically significant (HR=1.25;95%CI:0.81-1.91).
In the study among Italian men, the risk of total PrCA in the fourth quartile of eDII was practically the same as in the third quartile (ORQuartile4v.1 =1.33, 95% CI: 1.011.76 vs. ORQuartile3v.1=1.32, 95% CI:1.03-1.69, respectively) and there was no statistically
significant trend in the other two studies (181, 267). These observations may suggest the
possibility of a non-linear relationship between diet and PrCA, and a possible threshold
effect. The study among French men investigated dose-response relationships between
the DII and prostate cancer using restricted cubic splines (267). Men with DII ≥ -1.0 had
2.3-fold increased PrCA risk relative to those with DII < -1.0 (HR: 2.31; 95%CI: 1.353.95; P =0.002) (267). Previously, increased PrCA risk among men in the Jamaican,
Italian and French studies were observed for DII quartiles that were ≥ -1.0 (82, 181, 267).
In this study, the incidence of high-risk PrCA was significantly increased only in the third
quartile that included e-DII values of ≥ -1.0 (Q3: -2.0313 to ≤ -0.5517). The absence of
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increased PrCA risk among those in the highest e-DII quartile also may be related to
confounding by unknown factor, measurement error, or may suggest an overall lack of
association.
Differences in dietary intakes and food parameters available for the DII
calculations and use of the e-DII instead of the DII to calculate risk, have contributed to
the differences in the risk estimates between this study and others published to date. For
instance, the first and second quartiles of e-DII in this study were considerably more
negative than those in the previous PrCA studies (82, 181, 267). The range of actual DII
in this study was clearly larger (-6.28 to 4.69) than in other PrCA studies: Jamaican study
(-3.14 to 2.77) and the French study (-5.0 to 5.3) (82, 181, 267). Compared to other large
cohorts, such as National Institutes of Health–American Associations of Retired Persons
Diet and Health Study individuals (NIH-AARP), that explored the relationships between
the DII and a risk of colorectal cancer, quartiles in this study were more negative,
indicating an overall healthier diet in this study population (174).
The strengths of this study include a robust sample size among a diverse cohort
with prospectively collected data, extended follow-up (up to 12 years), rigorous case
ascertainment, and ample information on potential confounders. Because the diet was
assessed prior to the development of the outcome, differential recall was not an issue. The
sensitivity analyses indicated that, after the exclusion of cases diagnosed during the first 3
years of follow-up, the results did not change; thus, it is unlikely that reverse causation
played a significant role. About forty percent of the study population was represented by
different racial and ethnic groups (Asian, Black, Hispanic and Filipinos). The FFQ was
modified for use among men and to include foods commonly eaten by previously
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mentioned ethnic groups; it was also translated into Spanish and Chinese. Thus, any
significant misclassification of the exposure is unlikely.
One limitation of this study is that the information about diet was assessed only at
baseline with a single FFQ. Thus, it is possible that temporal changes in inflammatory
effect of diet on tumor development could not be captured. Previous research indicates
that dietary patterns in adulthood are fairly stable over time (275-278). Moreover,
previous large prospective studies that used diet assessment only at baseline found that
higher DII scores were associated with statistically significant increased risks for chronic
disease, including cancer, and increased mortality (171, 174, 175, 270).
Another study limitation was that the sample sizes and statistical power may have
been limited for assessment of the relationship between the e-DII and PrCA risk among
sub-strata of race or PrCA aggressiveness.
In summary, the results of this study suggest that a pro-inflammatory diet was
associated with 16% increase in total PrCA risk among middle-age White men. The
inflammatory potential of diet was associated with increases in high-risk PrCA incidence.
However, the patterns of risk observed across quartiles complicate the interpretation,
suggesting either a complex dose-response pattern (non-linear relationship with possible
threshold effect), or a lack of association. The relationship between the inflammatory
potential of a diet and PrCA may vary by race; Blacks and those of non-White (or mixed)
races may be more susceptible. The relationship between dietary inflammatory potential
and risk of advanced /aggressive disease merits further investigation, particularly among
those of racial or ethnic minorities.
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Table 6.1 Participants' characteristics (n, %) by quartiles of Energy-Density Dietary
Inflammatory Index at baseline, California Men's Health Study 2002-2014
Characteristic

Age at baseline
44-50
51-55
56-60
61- 65
66-70
Race
White
Black
Asian
Hispanic
Multiethnic/Other
Body mass index , kg/m2
Normal, < 25
Overweight, 25 to <30
Obese, ≥30
Education
High school,
equivalent or less
Vocational/tech
school
Some college,
associate or bachelor
degree
Graduate/professional
school
Missing
Income, $
<40,000
40-59,000
60-80,000
80-100,000
>100,000
Missing
Marital status
Married/living with a
partner
Single
Missing
Total physical activity,
MET-min/week

Q1: -6.1940 to
≤-3.3597
(the
healthiest)
n= 10042

Q2: -3.3597 to
≤-2.0313
n= 10040

Q3: -2.0313 to
≤-0.5517
n= 10040

Q4: -0.5517 to
4.8927
(the least
healthy)
n=10039

1649 (16.4)
2006 (20.0)
2223 (22.1)
2312 (23.1)
1852 (18.4)

1884 (18.8)
2173 (21.6)
2132 (21.2)
2050 (20.4)
1801 (18.0)

2122 (21.1)
2236 (22.3)
2126 (21.2)
1936 (19.3)
1620 (16.1)

2447 (24.4)
2363 (24.5)
2136 (21.3)
1731 (17.2)
1362 (13.6)

6989 (69.6)
429 (4.3)
973 (9.7)
793 (7.9)
858 (8.5)

6555 (65.3)
483 (4.8)
1128 (11.2)
973 (9.7)
901 (9.0)

6380 (63.6)
606 (6.0)
923 (9.2)
1148 (11.4)
983 (9.8)

6212 (61.9)
801 (8.0)
852 (8.5)
1121 (11.2)
1053 (10.5)

3388 (33.7)
4572 (45.5)
1946 (19.4)

2876 (28.7)
4694 (46.7)
2329 (23.2)

2488 (24.8)
4750 (47.3)
2660 (26.5)

2191 (21.8)
4442 (44.3)
3210 (32.0)

1510 (15.0)

1934 (12.3)

2349 (23.4)

2822 (28.1)

2451 (24.4)

2766 (27.6)

2977 (29.7)

3393 (33.8)

2267 (22.6)

2304 (22.9)

2304 (22.9)

2019 (20.1)

3776 (37.6)

2996 (29.8)

2377 (23.7)

1753 (14.5)

38 (0.4)

40 (0.4)

33 (0.3)

52 (0.5)

1421 (14.1)
1565 (15.6)
1649 (16.4)
1382 (13.8)
3616 (36.0)
409 (4.1)

1630 (16.2)
1772 (17.7)
1784 (17.8)
1433 (14.3)
3026 (30.1)
395 (3.9)

1850 (18.4)
1864 (18.6)
1861 (18.5)
1352 (13.5)
2745 (27.3)
368 (3.7)

2112 (21.0)
2020 (20.1)
1865 (18.6)
1370 (13.7)
2296 (22.9)
376 (3.7)

8463 (84.3)

8322 (82.9)

8234 (82.0)

7871 (78.4)

1539 (15.3)
40 (0.4)

1699 (16.9)
19 (0.2)

1776 (17.7)
30 (0.3)

2129 (21.2)
39 (0.4)
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0-359
1401 (13.9)
360-1102
2229 (22.2)
1103-2201
2743 (27.3)
>2202
3653 (36.4)
Missing
16 (0.2)
Sleep duration, hr/day
≤6
2115 (21.1)
7
2959 (29.5)
≥8
2284 (22.7)
Missing
2684 (26.7)
NSAID regular1 use
No
7032 (70.0)
Yes
1268 (12.6)
Missing
1742 (17.4)
Multivitamin regular1 use
No
4392 (43.7)
Yes
5650 (56.3)
Smoking status
Non-smoker
4626 (46.1)
Former smoker
4666 (46.5)
Current smoker
511 (5.1)
Missing
239 (2.4)
Diabetes
No
8894 (88.6)
Yes
1148 (11.4)
Benign prostatic
hyperplasia
No
7459 (74.3)
Yes
2201 (21.9)
Missing
382 (3.8)
Family history of prostate
cancer2
No
8792 (87.6)
Yes
1250 (12.4)
1
Use 3-4 times per week.
2
Father or brother had prostate cancer.

2125 (21.2)
2504 (24.9)
2638 (26.3)
2753 (27.4)
20 (0.2)

2744 (27.3)
2649 (26.4)
2488 (24.8)
2137 (21.3)
22 (0.2)

3749 (37.3)
2635 (26.2)
2144 (21.4)
1484 (14.8)
27 (0.3)

2209 (22.0)
2733 (27.2)
2085 (20.8)
3013 (30.0)

2235 (22.3)
2574 (25.6)
2055 (20.5)
3176 (31.6)

2271 (22.6)
2278 (22.7)
1873 (18.7)
3617 (36.3)

6851 (68.2)
1330 (13.3)
1859 (18.5)

6646 (66.2)
1478 (14.7)
1916 (19.1)

6556 (65.3)
1607 (16.0)
1876 (18.7)

5022 (50.0)
5018 (50.0)

5430 (54.1)
4610 (45.9)

6034 (60.1)
4005 (39.9)

4471 (44.5)
4544 (45.3)
782 (7.8)
243 (2.4)

4150 (41.3)
4601 (45.8)
1061 (10.6)
228 (2.3)

3692 (36.8)
4430 (44.1)
1624 (16.2)
293 (2.9)

8805 (87.7)
1235 (12.3)

8753 (87.2)
1287 (12.8)

8883 (88.5)
1156 (11.5)

7548 (75.2)
2075 (20.7)
417 (4.2)

7691 (76.6)
1897 (18.9)
452 (4.5)

7899 (78.7)
1705 (17.0)
435 (4.3)

8811 (87.8)
1229 (12.2)

8737 (87.0)
1303 (13.0)

8799 (87.6)
1240 (12.4)
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Table 6.2 Relationships between quartiles of Energy-Density DII and incidence of Prostate Cancer of any stage

Sleep duration is not
included in confounder
selection
Sleep duration modeled as
a dummy variable
Men with missing sleep
duration removed
Men diagnosed with
prostate cancer during first
3 y. of follow up removed
Stratified by Race
White

Q1: -6.1940 to
≤-3.3597

Q2:- 3.3598 to
≤-2.0313

Q3: -2.0314 to
≤-0.5517

Q4: -0.5518 to
4.8927

e-DII continuous,
AF (95%CI)

N with PrCA
AF (95%CI)1

640
1.00 (Ref.)

621
0.98 (0.88-1.09)

621
0.95 (0.85-1.06)

522
1.05 (0.94-1.18)

2,404
1.01 (0.98-1.03)

N with PrCA
AF (95%CI)2
N with PrCA2
AF (95%CI)2
N with PrCA2
AF (95%CI)2

636
1.00 (Ref.)
461
1.00 (Ref.)
456
1.00 (Ref.)

609
0.998 (0.90-1.11)
428
0.995 (0.90-1.11)
441
0.99 (0.92-1.07)

616
0.96 (0.86-1.06)
449
0.92 (0.83-1.02)
483
0.92 (0.85-0.99)

514
1.07 (0.95-1.20)
345
1.04 (0.93-1.16)
372
1.03 (0.95-1.11)

2,375
1.01 (0.99-1.03)
1,683
1.00 (0.98-1.02)
1,752
1.00 (0.98-1.01)
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N with PrCA
481
423
418
315
1,637
AF (95%CI)2
1.00 (Ref.)
1.02 (0.90-1.16)
0.96 (0.84-1.09) 1.16 (1.01-1.34)
1.02 (1.00-1.05)
Black
N with PrCA
35
44
73
74
226
AF (95%CI)2
1.00 (Ref.)
0.89 (0.58-1.36)
0.65 (0.44-0.96) 0.75 (0.50-1.11)
0.95 (0.89-1.02)
Asian
N with PrCA
41
52
38
30
161
AF (95%CI)2
1.00 (Ref.)
0.92 (0.60-1.40)
0.95 (0.60-1.51) 0.99 (0.61-1.62)
1.03 (0.94-1.14)
Hispanic
N with PrCA
45
48
45
45
183
AF (95%CI)2
1.00 (Ref.)
1.09 (0.75-1.59)
1.36 (0.93-1.99) 1.22 (0.83-1.80)
1.04 (0.97-1.13)
Multiethnic/Other
N with PrCA
34
42
42
50
168
AF (95%CI)2
1.00 (Ref.)
0.79 (0.51-1.22)
0.80 (0.52-1.23) 0.68 (0.44-1.04)
0.92 (0.85-1.00)
Detailed legend: Accelerated failure time models with log-logistic distribution were used to estimate parameters.
AF: acceleration factor, CI: confidence interval, PrCA: Prostate Cancer.
1
Adjusted for age (in 5-year intervals), race, BPH, prostate cancer family history, diabetes, and smoking status. Only significant confounders were
kept in the model.
2
Adjusted for age (in 5-year intervals), race, sleep (categorical), BPH, BMI (categorical), prostate cancer family history, diabetes, and smoking
status. Physical activity was not a significant confounder.
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Table 6.3 Relationships between Energy-Density DII and High- and Intermediate-high risk Prostate Cancer
Q1: -6.1940
to
≤-3.3597
(healthiest)
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High-risk prostate cancer
N with prostate cancer
100
Age adjusted, HR (95%CI)
1.00 (Ref.)
HR (95%CI)1
1.00 (Ref.)
Men with missing sleep duration excluded
N with prostate cancer
78
1
HR (95%CI)
1.00 (Ref.)
Cases diagnosed during first 3 years removed
N with prostate cancer
83
1
HR (95%CI)
1.00 (Ref.)
Stratified by race1
White with prostate cancer (n)
73
HR (95%CI)1
1.00 (Ref.)
Black with prostate cancer (n)
4
HR (95%CI)1
1.00 (Ref.)
Asian with prostate cancer (n)
10
1
HR (95%CI)
1.00 (Ref.)
Hispanic with prostate cancer (n)
9
HR (95%CI)1
1.00 (Ref.)
Multiethnic/Other with prostate
4
cancer (n)
HR (95%CI)1
1.00 (Ref.)
Intermediate-risk prostate cancer
N with prostate cancer
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Age adjusted, HR (95%CI)
1.00 (Ref.)
HR (95%CI)2
1.00 (Ref.)

Q2:- 3.3598 to
≤-2.0313

Q3: -2.0314 to
≤-0.5517

Q4: -0.5518 to
≤4.8927
(least healthy)

123
1.28 (0.98-1.67)
1.27 (0.98-1.66)

126
1.39 (1.07-1.80)
1.36 (1.04-1.76)

88
1.04 (0.78-1.38)
0.99 (0.74-1.32)

87
1.19 (0.88-1.62)

99
1.44 (1.07-1.94)

57
0.91 (0.65-1.28)

94
1.19 (0.88-1.59)

103
1.35 (1.01-1.81)

67
0.93 (0.67-1.28)

86
1.29 (0.95-1.76)
11
2.43 (0.77-7.64)
11
0.97 (0.41-2.30)
9
0.91 (0.36-2.28)
6

69
1.12 (0.81-1.56)
20
3.77 (1.29-11.06)
13
1.51 (0.66-3.46)
13
1.16 (0.49-2.72)
9

46
0.80 (0.55-1.16)
15
2.29 (0.76-6.94)
6
0.81 (0.30-2.24)
11
1.11 (0.46-2.70)
11

1.68 (0.47-5.97)

2.97 (0.94-9.34)

2.94 (0.92-9.43)

242
1.06 (0.88-1.26)
1.05 (0.88-1.26)

239
1.08 (0.90-1.30)
1.06 (0.88-1.26)

201
0.96 (0.79-1.16)
0.91 (0.76-1.10)

p-value
for tend

e-DII
continuous,
HR (95%CI)

0.97
0.74

437
1.03 (0.98-1.08)
1.02 (0.96-1.07)

0.91

321
1.02 (0.96-1.08)

0.99

347
1.02 (0.96-1.08)

NA
NA
NA
NA

274
0.97 (0.91-1.04)
50
1.10 (0.95-1.28)
40
1.03 (0.87-1.24)
42
1.04 (0.88-1.23)
30

NA

1.23 (1.03-1.48)

0.70
0.36

919
0.99 (0.96-1.03)
0.98 (0.95-1.02)

Men with missing sleep duration excluded
N with prostate cancer
172
168
185
131
656
HR (95%CI)2
1.00 (Ref.)
1.05 (0.85-1.30) 1.20 (0.98-1.48) 0.93 (0.74-1.17)
0.84
1.00 (0.96-1.04)
Cases diagnosed during first 3 years removed
N with prostate cancer
180
174
195
144
693
HR (95%CI)2
1.00 (Ref.)
1.01 (0.82-1.24) 1.15 (0.94-1.41) 0.89 (0.71-1.11)
0.53
0.99 (0.95-1.03)
Detailed legend: Cox proportional hazards models were used to calculate parameters.
1
Adjusted for race and BPH; sleep duration (categorical) and age (≤55, 55-65, >65 y.) are in strata statement. Physical activity was not a
significant confounder.
2
Adjusted for race, BPH, family history of prostate cancer; sleep duration (categorical) and age (≤55, 55-65, >65 y.) are in strata statement.

119

CHAPTER 7
Summary

This study showed that disrupted sleep and social jetlag in adults 21-35 years of
age remained stable within two years. By the end of the study, chronotype became on
average, 23 minutes earlier, most likely due to the phase advance among participants with
evening chronotypes. Whether the observations in the present study correspond to more chronic
sleep disruption that extends beyond two years remains to be determined. The demographic
characteristics identified in this study that may contribute to persistent sleep disruption include:
male sex, being a student, non-White race, low income, and evening chronotype. The further
identification of susceptible subgroups of young adults with persistent sleep disruption may
provide a health benefit to those individuals in terms of chronic disease prevention, given the
persistent character of insomnia and other sleep disorders and their reported association with
chronic diseases such as depression (37, 220, 239), obesity (213, 240, 241), diabetes (62, 120),
hypertension (63, 118, 242), CVD (65) and cancer (28).

Chronotype and SJL were not associated with any anthropometric indexes of
metabolic disorder. The relationships between disrupted sleep (SOL, SE, TST) and
central obesity or elevated SBP were only modest. Despite being a fairly strong predictor
for all sleep measures except SOL, chronotype seemed to modify rather than confound
the relationships between disrupted sleep and obesity or high blood pressure. Those with
poor sleep and morning chronotype were more likely to have excess body fat and central
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obesity. Evening types seemed to be more resilient to detrimental effects of sleep
disruption than morning types and only had increased chance of having high SBP if they
slept <6 hours. The discovery of the effect-modifying role of chronotype is novel
compared to the previous studies that either inferred that chronotype, SJL and sleep
confound each other's relationships with metabolic disorder (12, 49, 58) or that SJL
mediates the relationships between chronotype and obesity (56). Due to the lack of
association between chronotype or SJL with anthropometric measures, we were unable
totest the latter hypothesis. This study's findings suggest that the relationships between
sleep, chronotype, SJL and anthropometric indices are more complex than it was
previously hypothesized and deserve further investigation in the future studies.
A pro-inflammatory diet was associated with 16% increase in total PrCA risk
among middle-age White men while among all race combined the results were only
suggestive. The inflammatory potential of diet was associated with increases in high-risk
PrCA incidence. However, the patterns of risk observed across quartiles of e-DII
complicate the interpretation, suggesting either a complex dose-response pattern (nonlinear relationship with possible threshold effect), or a lack of association. The
relationship between the inflammatory potential of a diet and PrCA may vary by race;
Blacks and those of non-White (or mixed) races may be more susceptible. The
relationship between dietary inflammatory potential and risk of advanced /aggressive
disease merits further investigation, particularly among those of racial or ethnic
minorities.
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APPENDIX A
Chronotype estimation

Time (in minutes) from midnight to the sleep onset the next day and from the
following midnight to the wake up time on the following day was calculated using the
SWA data. During calculation of chronotype, minutes were converted into hours. Since
the information on work schedule was not collected in this study, it was assumed that free
days occurred only on weekends. The first step in calculation of chronotype was
calculation of the mid-point of sleep on free days (MSF) using the following formulas:
a. If a study participant went to bed before midnight (the bed time on the weekend
(SOwkend) ≤ 1440 minutes), then
MSF= (WTwkend -((1440- SOwkend+WTwkend)/2))/60 (hours),
where WTwkend - wake time on the weekend;
b. If a study participant went to bed after midnight (SOwkend >1440 minutes), then
MSF=( WTwkend -(( WTwkend -(SOwkend -1440))/2))/60 (hours)
The MSF was corrected for make-up sleep on free days (weekends in this study)
(MSFsc)[8]. The “oversleep” is an excessive time spent asleep on a weekend to
compensate for sleep deprivation during the working week. The MSFsc was calculated
using the formula:
MSFsc = MSF - (SDwkend - SD)/2,

where SDwkend – sleep duration on free days (weekend);
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SD – average sleep duration across the week (includes sleep duration on all available
week and weekend nights).
The MSF is adjusted for make-up sleep only in study participants who sleep
longer on free days (weekend) than on work days. In persons who sleep longer on work
days, chronotype is defined as MSF:
MSFsc = MSF
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APPENDIX B:
Chronotype, Social Jetlag, Mood and Stress

In adjusted analyses, chronotype was not associated with mood and stress. Later
chronotypes were associated with reduced risk of having bad sleep assessed with PSQI
(Table B.1). Per 1 hour increase in lateness of chronotype, odds of bad sleep decreased
0.8 times (95%CI: 0.74-0.97).
Absolute SJL was not associated with TMD score and any of its six factors (Table
B.2). Per 1 hour increase in absolute SJL risk of high perceived stress decreased 0.8 times
(95%CI: 0.68-0.99). Stratification by latent chronotype group showed that among those
with intermediate chronotypes, Per 1 hour increase in SJL, odds of high stress decreased
0.7 times (95%CI: 0.57-0.94, pinteraction=0.44).
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Table B.1 Relationships between Chronotype, Mood, Stress, and Sleep
Quality
Variable
TMD score (cont.)
crude
adjusted1
Depression
crude
adjusted2
Tension-Anxiety
crude
Adjusted3
Fatigue
crude
Adjusted4
Confusionbewilderment
crude
Adjusted5
Anger-Hostility
crude
Adjusted6
Vigor
crude
Adjusted7
PSS (cont.)
crude
Adjusted8

Estimate

SE

p-value

0.03734
0.007626

0.03488
0.03528

0.29
0.83

0.02625
-0.02261

0.03647
0.03855

0.47
0.56

0.04439
0.01998

0.02123
0.02140

0.04
0.35

0.02463
0.01687

0.02163
0.02217

0.26
0.45

0.03226
0.009604

0.01760
0.01813

0.07
0.60

0.02940
0.003888

0.02826
0.02857

0.30
0.89

-0.2096
-0.2250

-0.2096
0.1557

0.19
0.15

0.07438
-0.04034
OR

0.1343
0.1335
95%CI

0.58
0.76
p-value

PSS (>12 vs. ≤12)
crude
1.04
0.93-1.17
0.51
9
adjusted
1.01
0.88-1.13
0.98
PSQI (>5 vs. ≤5)
crude
0.86
0.75-0.98
0.02
10
Adjusted
0.84
0.74-0.97
0.01
Detailed legend: Linear models with repeated measures and unstructured
correlation matrix (proc GLIMMIX). POMs, depression, tension modeled
using lognormal distribution, vigor and PSS score - normal distribution for
continuous variable). Dichotomous PSS score and PSQI were modeled with
binary distribution).
1
Adjusted for time, employment status, income, marital status, e-DII
(continuous), sleep duration on work days, social desirability score,
bulimia score, physical activity (continuous, MET-hrs), nap (yes/no)and
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perceived body image.
2
Adjusted for time, age, sex, alcohol, income, marital status, season, sleep
duration on work days, race, bulimia score, social desirability score and
perceived body image.
3
Adjusted for time, age, e-DII (cont.), employment status, social desirability
score, thinness score.
4
Adjusted for time, race, season, alcohol, e-DII (cont.),sleep duration on
work days, social desirability score, perceived body image and having
children.
5
Adjusted for time, income, race, marital status, e-DII (cont.), social
desirability score, bulimia score.
6
Adjusted for time, season, income, sleep duration on work days,
desirability score, thinness score, ideal body image and current diet.
7
Adjusted for time, sex, having children, physical activity (continuous, hrs),
e-DII continuous), social desirability score, smoking status.
8
Adjusted for time, age, sex, total sleep hours week day, physical activity
hours, e-DII, income, season, social desirability score, bulimia score.
9
Adjusted for time, sex, race, total number of hours slept on week night, eDII (cont.), social desirability score, bulimia score.
10
Adjusted for time, sleep duration on work days, social desirability score,
bulimia score.
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Table B.2 Relationships between Absolute Social Jetlag and Mood,
Stress, and Poor Sleep
Variable
TMD score (cont.)
crude
adjusted1
Depression
crude
adjusted2
Tension-Anxiety
crude
Adjusted3
Fatigue
crude
Adjusted4
Confusionbewilderment
crude
Adjusted5
Anger-Hostility
crude
Adjusted6
Vigor
crude
Adjusted7
PSS (cont.)
crude
Adjusted8

Estimate

SE

p-value

-0.08584
-0.07980

0.05492
0.05370

0.12
0.14

-0.05808
-0.02329

0.05894
0.05671

0.33
0.68

-0.02087
-0.01880

0.03014
0.02931

0.49
0.52

0.004596
-0.02227

0.03160
0.03103

0.88
0.47

-0.03416
-0.04562

0.02523
0.02455

0.18
0.06

-0.00995
-0.02826

0.04115
0.04033

0.81
0.48

-0.09702
0.01722

0.2236
0.2153

0.66
0.94

-0.4022
-0.4906
OR

0.1835
0.1792
95%CI

0.03
0.01

PSS (>12 vs. ≤12)
crude
0.87
0.73-1.05
0.14
adjusted9
0.82
0.68-0.99
0.04
10
Stratified by latent chronotype group (pinteraction=0.44)
Early
1.05
0.68-1.60
0.83
Intermediate
0.73
0.57-0.94
0.02
Late
0.81
0.42-1.54
0.51
PSQI (>5 vs. ≤5)
crude
0.91
0.75-1.11
0.37
Adjusted11
0.92
0.75-1.12
0.40
Detailed legend: Linear models with repeated measures and unstructured
correlation matrix (proc GLIMMIX). TMD score, depression, tension
modeled using lognormal distribution, vigor and PSS - normal distribution.
1
Adjusted for time, employment, sleep duration on work days, social
desirability score, bulimia score. 2 Adjusted for time, sex, race, income,
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marital status, season, sleep duration on work days, alcohol, caffeine
(tertiles), bulimia score and perceived body image. 3 Adjusted for time,
income, e-DII (cont.), employment, social desirability score and thinness
score. 4 Adjusted for time, race, e-DII, sleep duration on work days, social
desirability score, perceived body image, having children. 5 Adjusted for
time, marital status, total sleep duration on work days, social desirability
score, bulimia score. 6 Adjusted for time, season, current diet, social
desirability score, thinness score, ideal body image, sleep duration on work
days. 7 Adjusted for time, sex, physical activity (continuous, hrs),social
desirability score, having children, smoking status. 8 Adjusted for time, sex,
total sleep duration on work days (cont., hrs), e-DII (cont.), income, season,
social desirability score, bulimia score. 9 Adjusted for time, sex, race, e-DII
(cont.), total sleep duration on work days, social desirability score, bulimia
score. 10 Adjusted for time, sex, race, e-DII (cont.), total sleep duration on
work days, social desirability score, bulimia score. 11 Adjusted for time,
marital status, social desirability score and thinness score.
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